The present invention is directed to the area of implantable electrical stimulation systems and methods of making and using the systems. The present invention is also directed to systems and methods for selecting stimulation parameters using targeting and steering mechanisms.
Implantable electrical stimulation systems have proven therapeutic in a variety of diseases and disorders. For example, spinal cord stimulation systems have been used as a therapeutic modality for the treatment of chronic pain syndromes. Peripheral nerve stimulation has been used to treat chronic pain syndrome and incontinence, with a number of other applications under investigation. Functional electrical stimulation systems have been applied to restore some functionality to paralyzed extremities in spinal cord injury patients. Stimulation of the brain, such as deep brain stimulation, can be used to treat a variety of diseases or disorders.
Stimulators have been developed to provide therapy for a variety of treatments. A stimulator can include a control module (with a pulse generator), one or more leads, and an array of stimulator electrodes on each lead. The stimulator electrodes are in contact with or near the nerves, muscles, or other tissue to be stimulated. The pulse generator in the control module generates electrical pulses that are delivered by the electrodes to body tissue.
One embodiment is a system for identifying a set of stimulation parameters, the system includes a computer processor configured and arranged to perform the following actions: receiving a name of an anatomical or physiological target or a name of a disease or disorder; receiving a clinical goal; and using at least 1) the anatomical or physiological target or disease or disorder and 2) the clinical goal, selecting a set of stimulation parameters.
Another embodiment is a non-transitory computer-readable medium having processor-executable instructions for identifying a set of stimulation parameters, the processor-executable instructions when installed onto a device enable the device to perform actions, including: receiving a name of an anatomical or physiological target or a name of a disease or disorder; receiving a clinical goal; and using at least 1) the anatomical or physiological target or disease or disorder and 2) the clinical goal, selecting a set of stimulation parameters.
Yet another embodiment is a method for identifying a set of stimulation parameters. The method includes receiving a name of an anatomical or physiological target or a name of a disease or disorder; receiving a clinical goal; and using at least 1) the anatomical or physiological target or disease or disorder and 2) the clinical goal, selecting a set of stimulation parameters.
In at least some embodiments, the system, non-transitory computer-readable medium, or method described above further includes receiving a system goal, wherein selecting the set of stimulation parameters includes using the system goal to select the set of stimulation parameters. In at least some embodiments of the system, non-transitory computer-readable medium, or method described above, the system goal refers to one or more components of an electrical stimulation system or to one or more stimulation parameters and also refers to an objective related to the one or more components or stimulation parameters.
In at least some embodiments of the system, non-transitory computer-readable medium, or method described above, the clinical goal refers to the disease or disorder or to a symptom of the disease or disorder or to an effect or side effect associated with the disease or disorder or with electrical stimulation of the anatomical or physiological target.
In at least some embodiments, the system, non-transitory computer-readable medium, or method described above further includes receiving a user modification of at least one of the stimulation parameters. In at least some embodiments of the system, non-transitory computer-readable medium, or method described above, selecting the set of stimulation parameters further includes using previous stimulation instances or estimated stimulation instances to select the set of stimulation parameters. In at least some embodiments, the system, non-transitory computer-readable medium, or method described above further includes displaying an estimated stimulation region based on the selected set of stimulation parameters.
A further embodiment is a system for identifying a set of stimulation parameters, the system includes a computer processor configured and arranged to perform the following actions: providing a model of a lead including a plurality of electrodes, wherein the plurality of electrodes includes a plurality of segmented electrodes forming at least one set of segmented electrodes, wherein each set of segmented electrodes includes a plurality of the segmented electrodes disposed around a circumference of the lead at a same longitudinal position along the lead; receiving a selection of a target point external to the lead; projecting the target point onto a surface of the lead to identify a virtual electrode; and selecting a set of stimulation parameters for at least one of the electrodes to approximate an electrical field generated from the virtual electrode.
Another embodiment is a non-transitory computer-readable medium having processor-executable instructions for identifying a set of stimulation parameters, the processor-executable instructions when installed onto a device enable the device to perform actions, including: providing a model of a lead including a plurality of electrodes, wherein the plurality of electrodes includes a plurality of segmented electrodes forming at least one set of segmented electrodes, wherein each set of segmented electrodes includes a plurality of the segmented electrodes disposed around a circumference of the lead at a same longitudinal position along the lead; receiving a selection of a target point external to the lead; projecting the target point onto a surface of the lead to identify a virtual electrode; and selecting a set of stimulation parameters for at least one of the electrodes to approximate an electrical field generated from the virtual electrode.
Yet another embodiment is a method for identifying a set of stimulation parameters. The method includes providing a model of a lead including a plurality of electrodes, wherein the plurality of electrodes includes a plurality of segmented electrodes forming at least one set of segmented electrodes, wherein each set of segmented electrodes includes a plurality of the segmented electrodes disposed around a circumference of the lead at a same longitudinal position along the lead; receiving a selection of a target point external to the lead; projecting the target point onto a surface of the lead to identify a virtual electrode; and selecting a set of stimulation parameters for at least one of the electrodes to approximate an electrical field generated from the virtual electrode.
In at least some embodiments of the system, non-transitory computer-readable medium, or method described above, projecting the target point includes projecting the target point onto a nearest point of the surface of the lead to identify the virtual electrode. In at least some embodiments, the system, non-transitory computer-readable medium, or method described above further includes calculating the electrical field in a region that does not overlap with the lead and is bounded by a plane tangent to the lead at the virtual electrode. In at least some embodiments of the system, non-transitory computer-readable medium, or method described above, the electrical field is a scalar potential field, a vector field, or a field of Hamiltonians of a divergence of an electrical field.
In at least some embodiments, the system, non-transitory computer-readable medium, or method described above further includes receiving a user modification of at least one of the stimulation parameters. In at least some embodiments, the system, non-transitory computer-readable medium, or method described above, further includes defining at least one guarding electrode adjacent the virtual electrode. In at least some embodiments of the system, non-transitory computer-readable medium, or method described above, defining at least one guarding electrode includes defining two guarding electrodes circumferentially disposed on opposite sides of the virtual electrode.
A further embodiment is a system for identifying a set of stimulation parameters, the system includes a computer processor configured and arranged to perform the following actions: receiving a first set of stimulation parameters; receiving a command to alter the first set of stimulation parameters, wherein the command does not include, or is not composed exclusively of, a numerical value for any of the stimulation parameters; and modifying the first set of stimulation parameters to create a second set of stimulation parameters based on the command.
Another embodiment is a non-transitory computer-readable medium having processor-executable instructions for identifying a set of stimulation parameters, the processor-executable instructions when installed onto a device enable the device to perform actions, including: receiving a first set of stimulation parameters; receiving a command to alter the first set of stimulation parameters, wherein the command does not include, or is not composed exclusively of, a numerical value for any of the stimulation parameters; and modifying the first set of stimulation parameters to create a second set of stimulation parameters based on the command.
Yet another embodiment is a method for identifying a set of stimulation parameters. The method includes receiving a first set of stimulation parameters; receiving a command to alter the first set of stimulation parameters, wherein the command does not include, or is not composed exclusively of, a numerical value for any of the stimulation parameters; and modifying the first set of stimulation parameters to create a second set of stimulation parameters based on the command.
In at least some embodiments, the system, non-transitory computer-readable medium, or method described above further includes displaying an estimated stimulation region based on the first set of stimulation parameters. In at least some embodiments, the system, non-transitory computer-readable medium, or method described above further includes, upon modification of the first set of stimulation parameters to create the second set of stimulation parameters, modifying the display to display an estimated stimulation region based on the second set of stimulation parameters.
In at least some embodiments, the system, non-transitory computer-readable medium, or method described above further includes receiving a user modification of at least one of the stimulation parameters of the second set of stimulation parameters. In at least some embodiments, the system, non-transitory computer-readable medium, or method described above further includes repeating the actions with the second set of stimulation parameters becoming the first set of stimulation parameters for the repeated actions. In at least some embodiments, the system, non-transitory computer-readable medium, or method described above further includes sending the second set of stimulation parameters to an implantable pulse generator of an electrical stimulation system.
Non-limiting and non-exhaustive embodiments of the present invention are described with reference to the following drawings. In the drawings, like reference numerals refer to like parts throughout the various figures unless otherwise specified.
For a better understanding of the present invention, reference will be made to the following Detailed Description, which is to be read in association with the accompanying drawings, wherein:
The present invention is directed to the area of implantable electrical stimulation systems and methods of making and using the systems. The present invention is also directed to systems and methods for selecting stimulation parameters using targeting and steering mechanisms.
Suitable implantable electrical stimulation systems include, but are not limited to, a least one lead with one or more electrodes disposed on a distal end of the lead and one or more terminals disposed on one or more proximal ends of the lead. Leads include, for example, percutaneous leads, paddle leads, cuff leads, or any other arrangement of electrodes on a lead. Examples of electrical stimulation systems with leads are found in, for example, U.S. Pat. Nos. 6,181,969; 6,516,227; 6,609,029; 6,609,032; 6,741,892; 7,244,150; 7,450,997; 7,672,734; 7,761,165; 7,783,359; 7,792,590; 7,809,446; 7,949,395; 7,974,706; 8,175,710; 8,224,450; 8,271,094; 8,295,944; 8,364,278; 8,391,985; and 8,688,235; and U.S. Patent Applications Publication Nos. 2007/0150036; 2009/0187222; 2009/0276021; 2010/0076535; 2010/0268298; 2011/0005069; 2011/0004267; 2011/0078900; 2011/0130817; 2011/0130818; 2011/0238129; 2011/0313500; 2012/0016378; 2012/0046710; 2012/0071949; 2012/0165911; 2012/0197375; 2012/0203316; 2012/0203320; 2012/0203321; 2012/0316615; 2013/0105071; and 2013/0197602, all of which are incorporated by reference. In the discussion below, a percutaneous lead will be exemplified, but it will be understood that the methods and systems described herein are also applicable to paddle leads and other leads.
A percutaneous lead for electrical stimulation (for example, deep brain or spinal cord stimulation) includes stimulation electrodes that can be ring electrodes, segmented electrodes that extend only partially around the circumference of the lead, or any other type of electrode, or any combination thereof. The segmented electrodes can be provided in sets of electrodes, with each set having electrodes circumferentially distributed about the lead at a particular longitudinal position. For illustrative purposes, the leads are described herein relative to use for deep brain stimulation, but it will be understood that any of the leads can be used for applications other than deep brain stimulation, including spinal cord stimulation, peripheral nerve stimulation, or stimulation of other nerves, muscles, and tissues.
Turning to
The IPG 14 is physically connected, optionally via one or more lead extensions 24, to the stimulation lead(s) 12. Each lead carries multiple electrodes 26 arranged in an array. The IPG 14 includes pulse generation circuitry that delivers electrical stimulation energy in the form of, for example, a pulsed electrical waveform (i.e., a temporal series of electrical pulses) to the electrode array 26 in accordance with a set of stimulation parameters. The implantable pulse generator can be implanted into a patient's body, for example, below the patient's clavicle area or within the patient's buttocks or abdominal cavity. The implantable pulse generator can have eight stimulation channels which may be independently programmable to control the magnitude of the current stimulus from each channel. In some embodiments, the implantable pulse generator can have more or fewer than eight stimulation channels (e.g., 4-, 6-, 16-, 32-, or more stimulation channels). The implantable pulse generator can have one, two, three, four, or more connector ports, for receiving the terminals of the leads.
The ETS 20 may also be physically connected, optionally via the percutaneous lead extensions 28 and external cable 30, to the stimulation leads 12. The ETS 20, which may have similar pulse generation circuitry as the IPG 14, also delivers electrical stimulation energy in the form of, for example, a pulsed electrical waveform to the electrode array 26 in accordance with a set of stimulation parameters. One difference between the ETS 20 and the IPG 14 is that the ETS 20 is often a non-implantable device that is used on a trial basis after the neurostimulation leads 12 have been implanted and prior to implantation of the IPG 14, to test the responsiveness of the stimulation that is to be provided. Any functions described herein with respect to the IPG 14 can likewise be performed with respect to the ETS 20.
The RC 16 may be used to telemetrically communicate with or control the IPG 14 or ETS 20 via a uni- or bi-directional wireless communications link 32. Once the IPG 14 and neurostimulation leads 12 are implanted, the RC 16 may be used to telemetrically communicate with or control the IPG 14 via a uni- or bi-directional communications link 34. Such communication or control allows the IPG 14 to be turned on or off and to be programmed with different stimulation parameter sets. The IPG 14 may also be operated to modify the programmed stimulation parameters to actively control the characteristics of the electrical stimulation energy output by the IPG 14. The CP 18 allows a user, such as a clinician, the ability to program stimulation parameters for the IPG 14 and ETS 20 in the operating room and in follow-up sessions.
The CP 18 may perform this function by indirectly communicating with the IPG 14 or ETS 20, through the RC 16, via a wireless communications link 36. Alternatively, the CP 18 may directly communicate with the IPG 14 or ETS 20 via a wireless communications link (not shown). The stimulation parameters provided by the CP 18 are also used to program the RC 16, so that the stimulation parameters can be subsequently modified by operation of the RC 16 in a stand-alone mode (i.e., without the assistance of the CP 18).
For purposes of brevity, the details of the RC 16, CP 18, ETS 20, and external charger 22 will not be further described herein. Details of exemplary embodiments of these devices are disclosed in U.S. Pat. No. 6,895,280, which is expressly incorporated herein by reference. Other examples of electrical stimulation systems can be found at U.S. Pat. Nos. 6,181,969; 6,516,227; 6,609,029; 6,609,032; 6,741,892; 7,949,395; 7,244,150; 7,672,734; and U.S. Pat. Nos. 7,761,165; 7,974,706; 8,175,710; 8,224,450; and 8,364,278; and U.S. Patent Application Publication No. 2007/0150036, as well as the other references cited above, all of which are incorporated by reference.
In some embodiments, measurement devices coupled to the muscles or other tissues stimulated by the target neurons, or a unit responsive to the patient or clinician, can be coupled to the implantable pulse generator or microdrive motor system. The measurement device, user, or clinician can indicate a response by the target muscles or other tissues to the stimulation or recording electrode(s) to further identify the target neurons and facilitate positioning of the stimulation electrode(s). For example, if the target neurons are directed to a muscle experiencing tremors, a measurement device can be used to observe the muscle and indicate changes in, for example, tremor frequency or amplitude in response to stimulation of neurons. Alternatively, the patient or clinician can observe the muscle and provide feedback.
The lead 110 for deep brain stimulation can include stimulation electrodes, recording electrodes, or both. In at least some embodiments, the lead 110 is rotatable so that the stimulation electrodes can be aligned with the target neurons after the neurons have been located using the recording electrodes.
Stimulation electrodes may be disposed on the circumference of the lead 110 to stimulate the target neurons. Stimulation electrodes may be ring-shaped so that current projects from each electrode equally in every direction from the position of the electrode along a length of the lead 110. In the embodiment of
The lead 100 includes a lead body 110, terminals 135, and one or more ring electrodes 120 and one or more sets of segmented electrodes 130 (or any other combination of electrodes). The lead body 110 can be formed of a biocompatible, non-conducting material such as, for example, a polymeric material. Suitable polymeric materials include, but are not limited to, silicone, polyurethane, polyurea, polyurethane-urea, polyethylene, or the like. Once implanted in the body, the lead 100 may be in contact with body tissue for extended periods of time. In at least some embodiments, the lead 100 has a cross-sectional diameter of no more than 1.5 mm and may be in the range of 0.5 to 1.5 mm. In at least some embodiments, the lead 100 has a length of at least 10 cm and the length of the lead 100 may be in the range of 10 to 70 cm.
The electrodes 125 can be made using a metal, alloy, conductive oxide, or any other suitable conductive biocompatible material. Examples of suitable materials include, but are not limited to, platinum, platinum iridium alloy, iridium, titanium, tungsten, palladium, palladium rhodium, or the like. Preferably, the electrodes are made of a material that is biocompatible and does not substantially corrode under expected operating conditions in the operating environment for the expected duration of use.
Each of the electrodes can either be used or unused (OFF). When the electrode is used, the electrode can be used as an anode or cathode and carry anodic or cathodic current. In some instances, an electrode might be an anode for a period of time and a cathode for a period of time.
Deep brain stimulation leads may include one or more sets of segmented electrodes. Segmented electrodes may provide for superior current steering than ring electrodes because target structures in deep brain stimulation are not typically symmetric about the axis of the distal electrode array. Instead, a target may be located on one side of a plane running through the axis of the lead. Through the use of a radially segmented electrode array (“RSEA”), current steering can be performed not only along a length of the lead but also around a circumference of the lead. This provides precise three-dimensional targeting and delivery of the current stimulus to neural target tissue, while potentially avoiding stimulation of other tissue. Examples of leads with segmented electrodes include U.S. Pat. Nos. 8,473,061; 8,571,665; and 8,792,993; U.S. Patent Application Publications Nos. 2010/0268298; 2011/0005069; 2011/0130803; 2011/0130816; 2011/0130817; 2011/0130818; 2011/0078900; 2011/0238129; 2012/0016378; 2012/0046710; 2012/0071949; 2012/0165911; 2012/197375; 2012/0203316; 2012/0203320; 2012/0203321; 2013/0197424; 2013/0197602; 2014/0039587; 2014/0353001; 2014/0358208; 2014/0358209; 2014/0358210; 2015/0045864; 2015/0066120; 2015/0018915; 2015/0051681; U.S. patent application Ser. Nos. 14/557,211 and 14/286,797; and U.S. Provisional Patent Application Ser. No. 62/113,291, all of which are incorporated herein by reference.
An electrical stimulation lead can be implanted in the body of a patient (for example, in the brain or spinal cord of the patient) and used to stimulate surrounding tissue. In at least some embodiments, it is useful to estimate the effective region of stimulation (often called a volume of activation (VOA) or stimulation field model (SFM)) given the position of the lead and its electrodes in the patient's body and the stimulation parameters used to generate the stimulation. Any suitable method for determining the VOA/SFM and for graphically displaying the VOA/SFM relative to patient anatomy can be used including those described in, for example, U.S. Pat. Nos. 8,326,433; 8,675,945; 8,831,731; 8,849,632; and 8,958,615; U.S. Patent Application Publications Nos. 2009/0287272; 2009/0287273; 2012/0314924; 2013/0116744; 2014/0122379; and 2015/0066111; and U.S. Provisional Patent Application Ser. No. 62/030,655, all of which are incorporated herein by reference. Several of these references also discloses methods and systems for registering an atlas of body structures to imaged patient physiology.
In conventional systems, a VOA is determined based on a set of stimulation parameters input into the system. The VOA can then be modified by the user by modifying the stimulation parameters and determining the new VOA from the modified stimulation parameters. This allows the user to tailor the stimulation volume.
In contrast to these conventional systems which determine the VOA from user-selected stimulation parameters, in at least some embodiments, the present systems or methods allow the user to define the target that is desired for stimulation and then the systems or methods determine a set of stimulation parameters based on that target. There are a number of different methods for selecting a desired stimulation target described below. In some embodiments, the user selects the volume directly. In other embodiments, the user selects the target indirectly by indicating an anatomical structure, disease or disorder, clinical goal, or system goal, or any combination thereof.
The computing device 300 can be a computer, tablet, mobile device, or any other suitable device for processing information. The computing device 300 can be local to the user or can include components that are non-local to the computer including one or both of the processor 302 or memory 304 (or portions thereof). For example, in some embodiments, the user may operate a terminal that is connected to a non-local computing device. In other embodiments, the memory can be non-local to the user.
The computing device 300 can utilize any suitable processor 302 including one or more hardware processors that may be local to the user or non-local to the user or other components of the computing device. The processor 302 is configured to execute instructions provided to the processor, as described below.
Any suitable memory 304 can be used for the computing device 302. The memory 304 illustrates a type of computer-readable media, namely computer-readable storage media. Computer-readable storage media may include, but is not limited to, nonvolatile, non-transitory, removable, and non-removable media implemented in any method or technology for storage of information, such as computer readable instructions, data structures, program modules, or other data. Examples of computer-readable storage media include RAM, ROM, EEPROM, flash memory, or other memory technology, CD-ROM, digital versatile disks (“DVD”) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information and which can be accessed by a computing device.
Communication methods provide another type of computer readable media; namely communication media. Communication media typically embodies computer-readable instructions, data structures, program modules, or other data in a modulated data signal such as a carrier wave, data signal, or other transport mechanism and include any information delivery media. The terms “modulated data signal,” and “carrier-wave signal” includes a signal that has one or more of its characteristics set or changed in such a manner as to encode information, instructions, data, and the like, in the signal. By way of example, communication media includes wired media such as twisted pair, coaxial cable, fiber optics, wave guides, and other wired media and wireless media such as acoustic, RF, infrared, and other wireless media.
The display 306 can be any suitable display device, such as a monitor, screen, display, or the like, and can include a printer. The input device 308 can be, for example, a keyboard, mouse, touch screen, track ball, joystick, voice recognition system, or any combination thereof, or the like.
One or more imaging systems 310 can be used including, but not limited to, MRI, CT, ultrasound, or other imaging systems. The imaging system 310 may communicate through a wired or wireless connection with the computing device 300 or, alternatively or additionally, a user can provide images from the imaging system 310 using a computer-readable medium or by some other mechanism.
The electrical stimulation system 312 can include, for example, any of the components illustrated in
The methods and systems described herein may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Accordingly, the methods and systems described herein may take the form of an entirely hardware embodiment, an entirely software embodiment or an embodiment combining software and hardware aspects. Systems referenced herein typically include memory and typically include methods for communication with other devices including mobile devices. Methods of communication can include both wired and wireless (e.g., RF, optical, or infrared) communications methods and such methods provide another type of computer readable media; namely communication media. Wired communication can include communication over a twisted pair, coaxial cable, fiber optics, wave guides, or the like, or any combination thereof. Wireless communication can include RF, infrared, acoustic, near field communication, Bluetooth™, or the like, or any combination thereof.
Programming an electrical stimulation (for example, a deep brain stimulation (DBS) or spinal cord stimulation (SCS)) system has conventionally involved significant time spent by a variety of programming experts, having varying levels of training and experience, with those programmers subscribing to various schools of thought regarding the choice of stimulation parameters. A preferred programming solution would offer tools to users or programmers to program more quickly, to more often arrive at efficacious sets of stimulation parameters, and to increase the efficacy of the patient's therapy.
In at least some embodiments, two different tasks can be identified: Targeting and Steering. Targeting can refer to, for example, an automated or semi-automated selection of a set of stimulation parameters based on any number or type of data or criteria. Steering (for example, current steering) can refer to the automated or semi-automated selection of sets of stimulation parameters resulting in stepwise changes to stimulation, again based on any number of type of data or criteria. In at least some embodiments, targeting can be the selection of a final set of stimulation parameters which achieve a desired stimulation goal, and steering can be a method of exploring the stimulation parameter space using, for example, abstracted controls.
In one embodiment of a method of selecting stimulation parameters (e.g., targeting), the user employs alphanumeric descriptors, instead of visual or graphical views, to describe the objective of the electrical stimulation therapy. The system can use these alphanumeric descriptors, as well as data from actual or estimated stimulation instances, to select at least one set of stimulation parameters to achieve the described objective. In at least some embodiments, no graphical views are presented to the user. In at least some embodiments, no imaging data is required. In some other embodiments, imaging data related to surgical placement of the lead or imaging data of the anatomical structures in which the lead is (or is to be) placed, or graphical data relating to physiological structures or responses to stimulation mapped to 3D or anatomical space or a common space, such as MNI space, or any combination thereof may optionally be provided.
In step 404, the user provides the name of a disease or disorder (e.g. Parkinson's disease, depression, epilepsy) that is to be treated. In some instances, the disease or disorder may be a symptom or condition associated with another disease or disorder. The user may input the name of the disease or disorder using a keyboard, touchscreen, voice-recognition system, or any other suitable input device. Additionally or alternatively, the user may select the disease or disorder from a list using, for example, a drop-down menu or any other suitable selection mechanism. In some embodiments, the system may present a list for the disease or disorder based on the previously provided anatomical or physiological target. In some embodiments, there can be more than one disease or disorder provided. In some embodiments, step 402 is skipped and the user-provided name from step 404 is utilized by the system to select a target (which can be an anatomical or physiological target) or to present a list of targets to the user.
In step 406, the user provides a clinical goal. In at least some embodiments, the clinical goal may be input as a verb/noun combination, for example, ‘reduce’+‘tremor’ or ‘avoid’+‘cognitive impairment’. The clinical goal generally refers the disease or disorder or to a symptom of the disease or disorder or to an effect or side effect associated with the disease or disorder or with electrical stimulation of the anatomical or physiological target. The user may input the clinical goal using a keyboard, touchscreen, voice-recognition system, or any other suitable input device. Additionally or alternatively, the user may select the clinical goal from a list using, for example, a drop-down menu or any other suitable selection mechanism. In some embodiments, the system may present a list for the clinical goal based on the previously provided anatomical or physiological target or provided disease or disorder or both. In some embodiments, there can be more than one clinical goal provided. In some embodiments, one or more clinical goals can be suggested by the system based on selections made in steps 402, 404, or 408.
In optional step 408, the user can provide a system goal, such as, for example, ‘extended battery life’, ‘low frequency’, ‘short pulse width’, or the like. The system goal generally refers to one or more of the components of the stimulation system or to one or more of the stimulation parameters and indicates an objective related to the component or parameter. The user may input the system goal using a keyboard, touchscreen, voice-recognition system, or any other suitable input device. Additionally or alternatively, the user may select the system goal from a list using, for example, a drop-down menu or any other suitable selection mechanism. In some embodiments, there can be more than one system goal provided. In some embodiments, one or more system goals can be suggested by the system based on selections made in steps 402, 404, or 406.
It will be understood that steps 402, 404, 406, and 408 can be rearranged in any order. In step 410, the system uses the provided inputs from steps 402, 404, 406, and 408 to select a set of stimulation parameters. In at least some embodiments, the system can utilize previous actual or estimated stimulation instances to correlate with the selections or inputs made by the user. For example, the anatomical or physiological target and, optionally, the disease or disorder and clinical goal, may be used to identify a target region for stimulation. In some embodiments, the anatomical or physiological target, disease or disorder, clinical goal, or system goal (or any combination thereof) may provide limits (for example, ranges, maximum values, or minimum values, or sets of combinations of parameters) for one or more stimulation parameters. Examples of methods to determine stimulation parameters are described in more detail below.
In step 504, the user selects at least one target. In some embodiments, the user selects at least one anatomical target. For example, the user can select an anatomical target that is shown on a display using any suitable selection device, such as a touchscreen, mouse, touchpad, track ball, or the like, or the user can select an anatomical target from a drop-down menu or the like or the user can utilize any other suitable selection mechanism.
In other embodiments, the user can select at least one target volume, which is not a specific anatomical structure, but may include parts of one or more anatomical structures. The target volume may be displayed in the one or more views of the GUI. In at least some embodiments, the target volume can be drawn or otherwise indicated by the user. In at least some embodiments, a sample target volume can be displayed and the user can manipulate the sample target volume by, for example, changing boundaries of the sample target volume, changing a diameter of the sample target volume, or the like. In at least some embodiments, the target volume can be estimated based on, for example, a selection of disease state, surgical target, an auto-segmentation method, or the like and then, at least in some instances, optionally modified by the user.
Methods for selecting a target are illustrated using
In some embodiments, a target point 607 can be selected. In some embodiments, the target 603 or target point 607 is automatically placed by the system (using, for example, the input described above with respect to
A dashed line 610 in
In at least some embodiments, one or more targets 603 can be identified by the user. These targets 603 may be constructed using the GUI. A target 603 may be constructed entirely from scratch, or by using a set of primitives (for example, lines, spheres, cubes, rectangles, circles, triangles, or the like or any combination thereof), or in a stepwise fashion by modifying an initial target. For example, a user may place a sphere primitive in the space, and then modulate its radius or transition it to an ellipsoid with two axes. Targets may be combined as a union or an intersection to form final targets. Targets may be constructed out of a series of outlines in various planes. For example, the user may draw an outline on each of three orthogonal planes (e.g. first the xy plane, then the yz plane, then the xz plane.)
Returning to
In at least some embodiments, the user indicates a type of neurological intervention for each target. In some embodiments, a default type of neurological intervention (for example, stimulation or activation) is assumed unless the user selects a different type of neurological intervention. In some embodiments, the user can select the type of neurological intervention from a pull-down menu, optionally associated or displayed on the target, or by any other selection technique.
In optional step 508, the user provides the name of a disease or disorder (e.g. Parkinson's disease, depression, epilepsy) that is to be treated. In some instances, the disease or disorder may be a symptom or condition associated with another disease or disorder. The user may input the name of the disease or disorder using a keyboard, touchscreen, voice-recognition system, or any other suitable input device. Additionally or alternatively, the user may select the disease or disorder from a list using, for example, a drop-down menu or any other suitable selection mechanism. In some embodiments, the system may present a list for the disease or disorder based on the previously provided target. In some embodiments, there can be more than one disease or disorder provided.
In optional step 510, the user provides a clinical goal or a system goal or any combination thereof. In at least some embodiments, the clinical goal may be input as a verb/noun combination, for example, ‘reduce’+‘tremor’ or ‘avoid’+‘cognitive impairment’. The clinical goal generally refers to a disease or disorder or to a symptom of the disease or disorder or to a side-effect associated with the disease, disorder, or stimulation. The system goal generally refers to one or more of the components of the stimulation system or to one or more of the stimulation parameters and indicates an objection related to the component or parameter, such as, for example, ‘extended battery life’, ‘low frequency’, ‘short pulse width’, or the like. The user may input the clinical or system goal using a keyboard, touchscreen, voice-recognition system, or any other suitable input device. Additionally or alternatively, the user may select the clinical or system goal from a list using, for example, a drop-down menu or any other suitable selection mechanism. In some embodiments, the system may present a list for the clinical or system goal based on the previously provided target or provided disease or disorder or both. In some embodiments, there can be more than one clinical or system goal provided.
It will be understood that steps 504, 506, 508, or 510 can be rearranged in any order. In step 512, the system uses the provided inputs from steps 504, 506, 508, or 510 to select a set of stimulation parameters. In at least some embodiments, the system can utilize previous actual or estimated stimulation instances to correlate with the selections or inputs made by the user.
When selecting stimulation parameters, for example, according to step 410 in
Any suitable method can be used to select stimulation parameters including methods disclosed in copending U.S. Provisional Patent Application Ser. No. 62/186,184, entitled “Systems and Methods for Analyzing Electrical Stimulation and Selecting or Manipulating Volumes of Activation”, filed on even date herewith. The anatomical region that is stimulated for a particular set of stimulation parameters can be estimated using any suitable estimation technique. These estimates can include, for example, estimates of axonal activation, estimates of cell bodies that are activated, estimates of fiber pathways that are activated, and the like or any combination thereof. In at least some instances, the estimate is called a value of activation (VOA) or stimulation field model (SFM) Examples of suitable methods for making these estimations include, but are not limited to, those described in U.S. Pat. Nos. 8,326,433; 8,675,945; 8,831,731; 8,849,632; and 8,958,615; U.S. Patent Application Publications Nos. 2009/0287272; 2009/0287273; 2012/0314924; 2013/0116744; 2014/0122379; and 2015/0066111; and U.S. Provisional Patent Application Ser. No. 62/030,655, all of which are incorporated herein by reference. It will be understood that other methods of estimating the stimulation region that do not use the stimulation parameters can also be employed.
The estimated stimulation region can be compared to the target to determine correspondence to the target. In at least some embodiments, the system or user can set a threshold (for example, a percentage overlap between the estimated stimulation region and the target or a percentage difference between the target and the estimate stimulation region) which when met by the comparison indicates that a set of stimulation parameters can be accepted as a final set of stimulation parameters. In some embodiments, a set of stimulation parameters can be arrived at iteratively based on the comparison and subsequent modification of the stimulation parameters. Such an iterative process can be performed automatically by a processor or performed semi-automatically with occasional input from the user or can be performed with user input to direct which parameters to modify or the amount of the modifications. In other embodiments, a system may compare a target with previously determined estimations (for example, a set of previously calculated VOAs or SFMs) and select a set of parameters based on these comparisons.
In at least some embodiments, the set of stimulation parameters may include one or more subsets of stimulation parameters to provide a neuromodulation intervention for more than one (overlapping or non-overlapping) targets or to provide a neuromodulation intervention for a particular target at different times. The neuromodulation intervention in the multiple targets can be performed in time-dependent manner (e.g. target 1 occurs first, target 2 next, and so forth). Neuromodulation intervention in the multiple targets may or may not overlap spatially or temporally.
Targets, or estimated stimulation regions based on stimulation parameters, may be displayed to the user as a static image or as an animation (e.g. when multiple target volumes are present at multiple times). The display of targets, or estimated stimulation regions based on stimulation parameters, may be based on any type of construct, such as, for example, an electrical potential distribution, electric field, divergence of electric field (activating function), the Hermitian of the activating function, a Volume of Activation (VOA) model, or a Stimulation Field Model (SFM) or the like which considers the effects of the neuromodulation intervention on active neural elements in the target and deterministically quantifies the effect, allowing for the display of continuous (e.g. threshold) or discrete (e.g. binary fire/no-fire) data. Targets, or estimated stimulation regions based on stimulation parameters, may be displayed as 2D contours or 3D surfaces at a variety of thresholds (for example, electrical potential, electrical field, or the like which could be chosen by the user or method) or planar cutaways with overlayed false color maps. Different targets, or estimated stimulation regions based on stimulation parameters, may be distinguished by, for example, color, texture, luminosity, or the like.
In at least some embodiments, the user can modify the previously identified set of stimulation parameters. In at least some embodiments, an estimated stimulation region can be displayed based on the modified stimulation parameters.
In an alternative to the methods illustrated in
In step 704, the user provides an alphanumeric command to alter one or more of the stimulation parameters. In at least some embodiments, this command does not include, or is not composed exclusively of, a numerical value for any of the stimulation parameters. This command can include one or more words that direct modification of the stimulation parameters to obtain the goal recited in the command. Examples of such words include, but are not limited to, ‘up’, ‘down’, ‘left’, ‘right’, ‘clockwise’, ‘counter-clockwise’, ‘spread’, ‘focus’, ‘faster’, ‘slower’, ‘longer’, ‘shorter’, and so forth. These commands are abstract steering controls that can affect, for example, the number or selection of active electrodes, the polarity and amplitude of the electrodes, pulse width, frequency, amplitude, inter-pulse interval, regularity, and the like of the stimulation.
In optional step 706, the modification of the stimulation parameters is observed. In some embodiments, the modification can be observed, for example, by a change in a display of the representation of the field generated using these parameters or a volume of activation or a volume of stimulation generated using these parameters. In some embodiments, the modification can be observed as a stimulation effect or side effect that is noted by the user or patient. The user or patient may provide a rating of the stimulation parameters.
In step 708, the modification and observation steps (steps 704 and 706) can be repeated to perform further modifications of the stimulation parameters. This process can continue until a final set of stimulation parameters is obtained.
Using a graphical interface, in step 802 the user modifies the stimulation parameters. For example, the interface can include components for selecting which electrodes to activate; components for raising or lowering parameters such as amplitude, frequency, pulse width, or the length; and so forth. In other embodiments, the interface may permit the user to modify the field or volume of activation generated using the parameters and then the system can calculate the new set of stimulation parameters based on the modified field or volume.
In optional step 806, the modification of the stimulation parameters is observed. In some embodiments, the modification can be observed, for example, a change in a display of the representation of the field generated using these parameters or a volume of activation or a volume of stimulation generated using these parameters. In some embodiments, the modification can be observed as a stimulation effect or side effect that is noted by the user or patient. The user or patient may provide a rating of the stimulation parameters.
In step 808, the modification and observation steps (steps 804 and 806) can be repeated to perform further modifications of the stimulation parameters. This process can continue until a final set of stimulation parameters is obtained.
In at least some embodiments of a method of selecting stimulation parameters, a coarse exploration of the parameter space is made with abstracted steering controls (such as the methods in
The system then uses the extant electrodes 934 of the lead 902 to determine a best-fit (for example, using a least squares calculation) to this point source field by activating the electrodes using a set of stimulation parameters to approximate the point source field. The point source field may be a scalar potential field, a vector field (for example, an electric field, or divergence of the electric field), or a field of Hamiltonians of the divergence of the electric field, or the like. In some embodiments, the user can modify the resulting stimulation parameters to modify the field. For example, the user may ‘focus’ or ‘spread’ the field radially or longitudinally. In at least some embodiments, radial focus can involve the addition of anodes antipodal to the target point.
In another embodiment, the target electric field may be computed from combinations of pre-computed basis fields, or by the combination of solutions of analytic fits to pre-computed data.
Instead of designating a target point, a user can alternatively designate a virtual electrode and use this electrode to generate stimulation. The system can then select stimulation parameters using the actual electrodes of the lead to approximate the virtual electrode.
In some embodiments, edges or segments of edges of the virtual electrode can be set to ‘guard’ to reduce or prevent extending the field generated by the virtual electrode beyond the edges. For example, if the virtual electrode is a cathode, the guarded edges can provide anodic guarding. In at least some embodiments, the strength of guarding can be set, independently for each edge or segment.
In any of the systems and methods described above, when a set of stimulation parameters is determined, the set of stimulation parameters can be communicated to an IPG, ETS, or other device.
It will be understood that the system can include one or more of the methods described hereinabove with respect to
It will be understood that each block of the flowchart illustrations, and combinations of blocks in the flowchart illustrations and methods disclosed herein, can be implemented by computer program instructions. These program instructions may be provided to a processor to produce a machine, such that the instructions, which execute on the processor, create means for implementing the actions specified in the flowchart block or blocks disclosed herein. The computer program instructions may be executed by a processor to cause a series of operational steps to be performed by the processor to produce a computer implemented process. The computer program instructions may also cause at least some of the operational steps to be performed in parallel. Moreover, some of the steps may also be performed across more than one processor, such as might arise in a multi-processor computer system. In addition, one or more processes may also be performed concurrently with other processes, or even in a different sequence than illustrated without departing from the scope or spirit of the invention.
The computer program instructions can be stored on any suitable computer-readable medium including, but not limited to, RAM, ROM, EEPROM, flash memory or other memory technology, CD-ROM, digital versatile disks (“DVD”) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information and which can be accessed by a computing device.
The above specification provides a description of the structure, manufacture, and use of the invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, the invention also resides in the claims hereinafter appended.
This application claims the benefit under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 62/186,172, filed Jun. 29, 2015, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3999555 | Person | Dec 1976 | A |
4144889 | Tyers et al. | Mar 1979 | A |
4177818 | De Pedro | Dec 1979 | A |
4341221 | Testerman | Jul 1982 | A |
4378797 | Osterholm | Apr 1983 | A |
4445500 | Osterholm | May 1984 | A |
4735208 | Wyler et al. | Apr 1988 | A |
4765341 | Mower et al. | Aug 1988 | A |
4841973 | Stecker | Jun 1989 | A |
5067495 | Brehm | Nov 1991 | A |
5099846 | Hardy | Mar 1992 | A |
5222494 | Baker, Jr. | Jun 1993 | A |
5255693 | Dutcher | Oct 1993 | A |
5259387 | dePinto | Nov 1993 | A |
5304206 | Baker, Jr. et al. | Apr 1994 | A |
5344438 | Testerman et al. | Sep 1994 | A |
5361763 | Kao et al. | Nov 1994 | A |
5452407 | Crook | Sep 1995 | A |
5560360 | Filler et al. | Oct 1996 | A |
5565949 | Kasha, Jr. | Oct 1996 | A |
5593427 | Gliner et al. | Jan 1997 | A |
5601612 | Gliner et al. | Feb 1997 | A |
5607454 | Cameron et al. | Mar 1997 | A |
5620470 | Gliner et al. | Apr 1997 | A |
5651767 | Schulman | Jul 1997 | A |
5711316 | Elsberry et al. | Jan 1998 | A |
5713922 | King | Feb 1998 | A |
5716377 | Rise et al. | Feb 1998 | A |
5724985 | Snell et al. | Mar 1998 | A |
5749904 | Gliner et al. | May 1998 | A |
5749905 | Gliner et al. | May 1998 | A |
5776170 | MacDonald et al. | Jul 1998 | A |
5782762 | Vining | Jul 1998 | A |
5843148 | Gijsbers et al. | Dec 1998 | A |
5859922 | Hoffmann | Jan 1999 | A |
5868740 | LeVeen et al. | Feb 1999 | A |
5897583 | Meyer et al. | Apr 1999 | A |
5910804 | Fortenbery et al. | Jun 1999 | A |
5925070 | King et al. | Jul 1999 | A |
5938688 | Schiff | Aug 1999 | A |
5938690 | Law et al. | Aug 1999 | A |
5978713 | Prutchi et al. | Nov 1999 | A |
6016449 | Fischell et al. | Jan 2000 | A |
6029090 | Herbst | Feb 2000 | A |
6029091 | de la Rama et al. | Feb 2000 | A |
6050992 | Nichols | Apr 2000 | A |
6058331 | King | May 2000 | A |
6066163 | John | May 2000 | A |
6083162 | Vining | Jul 2000 | A |
6094598 | Elsberry et al. | Jul 2000 | A |
6096756 | Crain et al. | Aug 2000 | A |
6106460 | Panescu et al. | Aug 2000 | A |
6109269 | Rise et al. | Aug 2000 | A |
6128538 | Fischell et al. | Oct 2000 | A |
6129685 | Howard, III | Oct 2000 | A |
6146390 | Heilbrun et al. | Nov 2000 | A |
6161044 | Silverstone | Dec 2000 | A |
6167311 | Rezai | Dec 2000 | A |
6181969 | Gord | Jan 2001 | B1 |
6192266 | Dupree et al. | Feb 2001 | B1 |
6205361 | Kuzma | Mar 2001 | B1 |
6208881 | Champeau | Mar 2001 | B1 |
6240308 | Hardy et al. | May 2001 | B1 |
6246912 | Sluijter et al. | Jun 2001 | B1 |
6253109 | Gielen | Jun 2001 | B1 |
6289239 | Panescu et al. | Sep 2001 | B1 |
6301492 | Zonenshayn | Oct 2001 | B1 |
6310619 | Rice | Oct 2001 | B1 |
6319241 | King | Nov 2001 | B1 |
6336899 | Yamazaki | Jan 2002 | B1 |
6343226 | Sunde et al. | Jan 2002 | B1 |
6351675 | Tholen et al. | Feb 2002 | B1 |
6353762 | Baudino et al. | Mar 2002 | B1 |
6366813 | Dilorenzo | Apr 2002 | B1 |
6368331 | Front et al. | Apr 2002 | B1 |
6389311 | Whayne et al. | May 2002 | B1 |
6393325 | Mann et al. | May 2002 | B1 |
6421566 | Holsheimer | Jul 2002 | B1 |
6435878 | Reynolds et al. | Aug 2002 | B1 |
6442432 | Lee | Aug 2002 | B2 |
6463328 | John | Oct 2002 | B1 |
6491699 | Henderson et al. | Dec 2002 | B1 |
6494831 | Koritzinsky | Dec 2002 | B1 |
6507759 | Prutchi et al. | Jan 2003 | B1 |
6510347 | Borkan | Jan 2003 | B2 |
6516227 | Meadows et al. | Feb 2003 | B1 |
6517480 | Krass | Feb 2003 | B1 |
6539263 | Schiff | Mar 2003 | B1 |
6560490 | Grill et al. | May 2003 | B2 |
6579280 | Kovach et al. | Jun 2003 | B1 |
6600956 | Maschino et al. | Jul 2003 | B2 |
6606523 | Jenkins | Aug 2003 | B1 |
6609029 | Mann et al. | Aug 2003 | B1 |
6609031 | Law et al. | Aug 2003 | B1 |
6609032 | Woods et al. | Aug 2003 | B1 |
6622048 | Mann et al. | Sep 2003 | B1 |
6631297 | Mo | Oct 2003 | B1 |
6654642 | North et al. | Nov 2003 | B2 |
6662053 | Borkan | Dec 2003 | B2 |
6675046 | Holsheimer | Jan 2004 | B2 |
6684106 | Herbst | Jan 2004 | B2 |
6687392 | Touzawa et al. | Feb 2004 | B1 |
6690972 | Conley et al. | Feb 2004 | B2 |
6690974 | Archer et al. | Feb 2004 | B2 |
6692315 | Soumillon et al. | Feb 2004 | B1 |
6694162 | Hartlep | Feb 2004 | B2 |
6694163 | Vining | Feb 2004 | B1 |
6708096 | Frei et al. | Mar 2004 | B1 |
6741892 | Meadows et al. | May 2004 | B1 |
6748098 | Rosenfeld | Jun 2004 | B1 |
6748276 | Daignault, Jr. et al. | Jun 2004 | B1 |
6778846 | Martinez et al. | Aug 2004 | B1 |
6788969 | Dupree et al. | Sep 2004 | B2 |
6795737 | Gielen et al. | Sep 2004 | B2 |
6827681 | Tanner et al. | Dec 2004 | B2 |
6830544 | Tanner | Dec 2004 | B2 |
6845267 | Harrison et al. | Jan 2005 | B2 |
6850802 | Holsheimer | Feb 2005 | B2 |
6895280 | Meadows et al. | May 2005 | B2 |
6909913 | Vining | Jun 2005 | B2 |
6937891 | Leinders et al. | Aug 2005 | B2 |
6937903 | Schuler et al. | Aug 2005 | B2 |
6944497 | Stypulkowski | Sep 2005 | B2 |
6944501 | Hess | Sep 2005 | B1 |
6950707 | Whitehurst | Sep 2005 | B2 |
6969388 | Goldman et al. | Nov 2005 | B2 |
7003349 | Andersson et al. | Feb 2006 | B1 |
7003352 | Whitehurst | Feb 2006 | B1 |
7008370 | Tanner et al. | Mar 2006 | B2 |
7008413 | Kovach et al. | Mar 2006 | B2 |
7035690 | Goetz | Apr 2006 | B2 |
7043293 | Baura | May 2006 | B1 |
7047082 | Schrom et al. | May 2006 | B1 |
7047084 | Erickson et al. | May 2006 | B2 |
7050857 | Samuelsson et al. | May 2006 | B2 |
7054692 | Whitehurst et al. | May 2006 | B1 |
7136518 | Griffin et al. | May 2006 | B2 |
7058446 | Schuler et al. | Jun 2006 | B2 |
7082333 | Bauhahn et al. | Jul 2006 | B1 |
7107102 | Daignault et al. | Sep 2006 | B2 |
7126000 | Ogawa et al. | Oct 2006 | B2 |
7127297 | Law et al. | Oct 2006 | B2 |
7136695 | Pless et al. | Nov 2006 | B2 |
7142923 | North et al. | Nov 2006 | B2 |
7146219 | Sieracki et al. | Dec 2006 | B2 |
7146223 | King | Dec 2006 | B1 |
7151961 | Whitehurst | Dec 2006 | B1 |
7155279 | Whitehurst | Dec 2006 | B2 |
7167760 | Dawant et al. | Jan 2007 | B2 |
7177674 | Echauz et al. | Feb 2007 | B2 |
7181286 | Sieracki et al. | Feb 2007 | B2 |
7184837 | Goetz | Feb 2007 | B2 |
7191014 | Kobayashi et al. | Mar 2007 | B2 |
7209787 | Dilorenzo | Apr 2007 | B2 |
7211050 | Caplygin | May 2007 | B1 |
7216000 | Sieracki et al. | May 2007 | B2 |
7217276 | Henderson | May 2007 | B2 |
7218968 | Condie et al. | May 2007 | B2 |
7228179 | Campen et al. | Jun 2007 | B2 |
7231254 | DiLorenzo | Jun 2007 | B2 |
7236830 | Gliner | Jun 2007 | B2 |
7239910 | Tanner | Jul 2007 | B2 |
7239916 | Thompson et al. | Jul 2007 | B2 |
7239926 | Goetz | Jul 2007 | B2 |
7242984 | DiLorenzo | Jul 2007 | B2 |
7244150 | Brase et al. | Jul 2007 | B1 |
7252090 | Goetz | Aug 2007 | B2 |
7254445 | Law et al. | Aug 2007 | B2 |
7254446 | Erickson | Aug 2007 | B1 |
7257447 | Cates et al. | Aug 2007 | B2 |
7266412 | Stypulkowski | Sep 2007 | B2 |
7294107 | Simon et al. | Nov 2007 | B2 |
7295876 | Erickson | Nov 2007 | B1 |
7299096 | Balzer et al. | Nov 2007 | B2 |
7308302 | Schuler et al. | Dec 2007 | B1 |
7313430 | Urquhart | Dec 2007 | B2 |
7324851 | DiLorenzo | Jan 2008 | B1 |
7346382 | McIntyre et al. | Mar 2008 | B2 |
7388974 | Yanagita | Jun 2008 | B2 |
7450997 | Pianca et al. | Nov 2008 | B1 |
7463928 | Lee et al. | Dec 2008 | B2 |
7499048 | Sieracki et al. | Mar 2009 | B2 |
7505815 | Lee et al. | Mar 2009 | B2 |
7548786 | Lee et al. | Jun 2009 | B2 |
7565199 | Sheffield et al. | Jul 2009 | B2 |
7603177 | Sieracki et al. | Oct 2009 | B2 |
7617002 | Goetz | Nov 2009 | B2 |
7623918 | Goetz | Nov 2009 | B2 |
7650184 | Walter | Jan 2010 | B2 |
7657319 | Goetz et al. | Feb 2010 | B2 |
7672734 | Anderson et al. | Mar 2010 | B2 |
7676273 | Goetz et al. | Mar 2010 | B2 |
7680526 | McIntyre et al. | Mar 2010 | B2 |
7734340 | De Ridder | Jun 2010 | B2 |
7761165 | He et al. | Jul 2010 | B1 |
7783359 | Meadows | Aug 2010 | B2 |
7792590 | Pianca et al. | Sep 2010 | B1 |
7809446 | Meadows | Oct 2010 | B2 |
7826902 | Stone et al. | Nov 2010 | B2 |
7848802 | Goetz et al. | Dec 2010 | B2 |
7860548 | McIntyre et al. | Dec 2010 | B2 |
7904134 | McIntyre et al. | Mar 2011 | B2 |
7945105 | Jaenisch | May 2011 | B1 |
7949395 | Kuzma | May 2011 | B2 |
7974706 | Moffitt et al. | Jul 2011 | B2 |
8019439 | Kuzma et al. | Sep 2011 | B2 |
8175710 | He | May 2012 | B2 |
8180601 | Butson et al. | May 2012 | B2 |
8195300 | Gliner et al. | Jun 2012 | B2 |
8224450 | Brase | Jul 2012 | B2 |
8257684 | Covalin et al. | Sep 2012 | B2 |
8262714 | Hulvershorn et al. | Sep 2012 | B2 |
8271094 | Moffitt et al. | Sep 2012 | B1 |
8295944 | Howard et al. | Oct 2012 | B2 |
8326433 | Blum et al. | Dec 2012 | B2 |
8364278 | Pianca et al. | Jan 2013 | B2 |
8391985 | McDonald | Mar 2013 | B2 |
8429174 | Ramani et al. | Apr 2013 | B2 |
8452415 | Goetz et al. | May 2013 | B2 |
8473061 | Moffitt et al. | Jun 2013 | B2 |
8543189 | Paitel et al. | Sep 2013 | B2 |
8571665 | Moffitt et al. | Oct 2013 | B2 |
8606360 | Butson et al. | Dec 2013 | B2 |
8620452 | King et al. | Dec 2013 | B2 |
8675945 | Barnhorst et al. | Mar 2014 | B2 |
8688235 | Pianca et al. | Apr 2014 | B1 |
8792993 | Pianca et al. | Jul 2014 | B2 |
8831731 | Blum et al. | Sep 2014 | B2 |
8849632 | Sparks et al. | Sep 2014 | B2 |
8958615 | Blum et al. | Feb 2015 | B2 |
9248272 | Romero | Feb 2016 | B2 |
20010031071 | Nichols et al. | Oct 2001 | A1 |
20020032375 | Bauch et al. | Mar 2002 | A1 |
20020062143 | Baudino et al. | May 2002 | A1 |
20020087201 | Firlik et al. | Jul 2002 | A1 |
20020099295 | Gil et al. | Jul 2002 | A1 |
20020115603 | Whitehouse | Aug 2002 | A1 |
20020116030 | Rezei | Aug 2002 | A1 |
20020123780 | Grill et al. | Sep 2002 | A1 |
20020128694 | Holsheimer | Sep 2002 | A1 |
20020151939 | Rezai | Oct 2002 | A1 |
20020183607 | Bauch et al. | Dec 2002 | A1 |
20020183740 | Edwards et al. | Dec 2002 | A1 |
20020183817 | Van Venrooij et al. | Dec 2002 | A1 |
20030097159 | Schiff et al. | May 2003 | A1 |
20030149450 | Mayberg | Aug 2003 | A1 |
20030171791 | KenKnight et al. | Sep 2003 | A1 |
20030212439 | Schuler et al. | Nov 2003 | A1 |
20040034394 | Woods et al. | Feb 2004 | A1 |
20040044279 | Lewin et al. | Mar 2004 | A1 |
20040044378 | Holsheimer | Mar 2004 | A1 |
20040044379 | Holsheimer | Mar 2004 | A1 |
20040054297 | Wingeier et al. | Mar 2004 | A1 |
20040059395 | North et al. | Mar 2004 | A1 |
20040106916 | Quaid et al. | Jun 2004 | A1 |
20040133248 | Frei et al. | Jul 2004 | A1 |
20040152957 | Stivoric et al. | Aug 2004 | A1 |
20040181262 | Bauhahn | Sep 2004 | A1 |
20040186532 | Tadlock | Sep 2004 | A1 |
20040199216 | Lee et al. | Oct 2004 | A1 |
20040267330 | Lee et al. | Dec 2004 | A1 |
20050021090 | Schuler et al. | Jan 2005 | A1 |
20050033380 | Tanner et al. | Feb 2005 | A1 |
20050049649 | Luders et al. | Mar 2005 | A1 |
20050060001 | Singhal et al. | Mar 2005 | A1 |
20050060009 | Goetz | Mar 2005 | A1 |
20050070781 | Dawant et al. | Mar 2005 | A1 |
20050075689 | Toy et al. | Apr 2005 | A1 |
20050085714 | Foley et al. | Apr 2005 | A1 |
20050165294 | Weiss | Jul 2005 | A1 |
20050171587 | Daglow et al. | Aug 2005 | A1 |
20050228250 | Bitter et al. | Oct 2005 | A1 |
20050251061 | Schuler et al. | Nov 2005 | A1 |
20050261061 | Nguyen et al. | Nov 2005 | A1 |
20050261601 | Schuler et al. | Nov 2005 | A1 |
20050261747 | Schuler et al. | Nov 2005 | A1 |
20050267347 | Oster | Dec 2005 | A1 |
20050288732 | Schuler et al. | Dec 2005 | A1 |
20060004422 | De Ridder | Jan 2006 | A1 |
20060017749 | McIntyre et al. | Jan 2006 | A1 |
20060020292 | Goetz et al. | Jan 2006 | A1 |
20060069415 | Cameron et al. | Mar 2006 | A1 |
20060094951 | Dean et al. | May 2006 | A1 |
20060095088 | De Riddler | May 2006 | A1 |
20060155340 | Schuler et al. | Jul 2006 | A1 |
20060206169 | Schuler | Sep 2006 | A1 |
20060218007 | Bjorner et al. | Sep 2006 | A1 |
20060224189 | Schuler et al. | Oct 2006 | A1 |
20060235472 | Goetz et al. | Oct 2006 | A1 |
20060259079 | King | Nov 2006 | A1 |
20060259099 | Goetz et al. | Nov 2006 | A1 |
20070000372 | Rezai et al. | Jan 2007 | A1 |
20070017749 | Dold et al. | Jan 2007 | A1 |
20070027514 | Gerber | Feb 2007 | A1 |
20070043268 | Russell | Feb 2007 | A1 |
20070049817 | Preiss et al. | Mar 2007 | A1 |
20070067003 | Sanchez et al. | Mar 2007 | A1 |
20070078498 | Rezai et al. | Apr 2007 | A1 |
20070083104 | Butson et al. | Apr 2007 | A1 |
20070123953 | Lee et al. | May 2007 | A1 |
20070129769 | Bourget et al. | Jun 2007 | A1 |
20070135855 | Foshee et al. | Jun 2007 | A1 |
20070150036 | Anderson | Jun 2007 | A1 |
20070156186 | Lee et al. | Jul 2007 | A1 |
20070162086 | DiLorenzo | Jul 2007 | A1 |
20070162235 | Zhan et al. | Jul 2007 | A1 |
20070168004 | Walter | Jul 2007 | A1 |
20070168007 | Kuzma et al. | Jul 2007 | A1 |
20070185544 | Dawant et al. | Aug 2007 | A1 |
20070191887 | Schuler et al. | Aug 2007 | A1 |
20070191912 | Ficher et al. | Aug 2007 | A1 |
20070197891 | Shachar et al. | Aug 2007 | A1 |
20070203450 | Berry | Aug 2007 | A1 |
20070203532 | Tass et al. | Aug 2007 | A1 |
20070203537 | Goetz et al. | Aug 2007 | A1 |
20070203538 | Stone et al. | Aug 2007 | A1 |
20070203539 | Stone et al. | Aug 2007 | A1 |
20070203540 | Goetz et al. | Aug 2007 | A1 |
20070203541 | Goetz et al. | Aug 2007 | A1 |
20070203543 | Stone et al. | Aug 2007 | A1 |
20070203544 | Goetz et al. | Aug 2007 | A1 |
20070203545 | Stone et al. | Aug 2007 | A1 |
20070203546 | Stone et al. | Aug 2007 | A1 |
20070213789 | Nolan et al. | Sep 2007 | A1 |
20070213790 | Nolan et al. | Sep 2007 | A1 |
20070244519 | Keacher et al. | Oct 2007 | A1 |
20070245318 | Goetz et al. | Oct 2007 | A1 |
20070255321 | Gerber et al. | Nov 2007 | A1 |
20070255322 | Gerber et al. | Nov 2007 | A1 |
20070265664 | Gerber et al. | Nov 2007 | A1 |
20070276441 | Goetz | Nov 2007 | A1 |
20070282189 | Dan et al. | Dec 2007 | A1 |
20070288064 | Butson et al. | Dec 2007 | A1 |
20080027514 | DeMulling et al. | Jan 2008 | A1 |
20080039895 | Fowler et al. | Feb 2008 | A1 |
20080071150 | Miesel et al. | Mar 2008 | A1 |
20080081982 | Simon et al. | Apr 2008 | A1 |
20080086451 | Torres et al. | Apr 2008 | A1 |
20080103533 | Patel et al. | May 2008 | A1 |
20080114233 | McIntyre et al. | May 2008 | A1 |
20080114579 | McIntyre et al. | May 2008 | A1 |
20080123922 | Gielen et al. | May 2008 | A1 |
20080123923 | Gielen et al. | May 2008 | A1 |
20080133141 | Frost | Jun 2008 | A1 |
20080141217 | Goetz et al. | Jun 2008 | A1 |
20080154340 | Goetz et al. | Jun 2008 | A1 |
20080154341 | McIntyre et al. | Jun 2008 | A1 |
20080163097 | Goetz et al. | Jul 2008 | A1 |
20080183256 | Keacher | Jul 2008 | A1 |
20080188734 | Suryanarayanan et al. | Aug 2008 | A1 |
20080215118 | Goetz et al. | Sep 2008 | A1 |
20080227139 | Deisseroth et al. | Sep 2008 | A1 |
20080242950 | Jung et al. | Oct 2008 | A1 |
20080261165 | Steingart et al. | Oct 2008 | A1 |
20080269588 | Csavoy et al. | Oct 2008 | A1 |
20080300654 | Lambert et al. | Dec 2008 | A1 |
20080300797 | Tabibiazar et al. | Dec 2008 | A1 |
20090016491 | Li | Jan 2009 | A1 |
20090054950 | Stephens | Feb 2009 | A1 |
20090082640 | Kovach et al. | Mar 2009 | A1 |
20090082829 | Panken et al. | Mar 2009 | A1 |
20090112289 | Lee et al. | Apr 2009 | A1 |
20090118635 | Lujan et al. | May 2009 | A1 |
20090118786 | Meadows et al. | May 2009 | A1 |
20090149917 | Whitehurst et al. | Jun 2009 | A1 |
20090187222 | Barker | Jul 2009 | A1 |
20090196471 | Goetz et al. | Aug 2009 | A1 |
20090196472 | Goetz et al. | Aug 2009 | A1 |
20090198306 | Goetz et al. | Aug 2009 | A1 |
20090198354 | Wilson | Aug 2009 | A1 |
20090204192 | Carlton et al. | Aug 2009 | A1 |
20090208073 | McIntyre et al. | Aug 2009 | A1 |
20090210208 | McIntyre et al. | Aug 2009 | A1 |
20090242399 | Kamath et al. | Oct 2009 | A1 |
20090276008 | Lee et al. | Nov 2009 | A1 |
20090276021 | Meadows et al. | Nov 2009 | A1 |
20090281595 | King et al. | Nov 2009 | A1 |
20090281596 | King et al. | Nov 2009 | A1 |
20090287271 | Blum et al. | Nov 2009 | A1 |
20090287272 | Kokones et al. | Nov 2009 | A1 |
20090287273 | Carlton et al. | Nov 2009 | A1 |
20090287467 | Sparks et al. | Nov 2009 | A1 |
20090299164 | Singhal et al. | Dec 2009 | A1 |
20090299165 | Singhal et al. | Dec 2009 | A1 |
20090299380 | Singhal et al. | Dec 2009 | A1 |
20100010566 | Thacker et al. | Jan 2010 | A1 |
20100010646 | Drew et al. | Jan 2010 | A1 |
20100023103 | Elborno | Jan 2010 | A1 |
20100023130 | Henry et al. | Jan 2010 | A1 |
20100030312 | Shen | Feb 2010 | A1 |
20100049276 | Blum et al. | Feb 2010 | A1 |
20100049280 | Goetz | Feb 2010 | A1 |
20100064249 | Groetken | Mar 2010 | A1 |
20100076535 | Pianca et al. | Mar 2010 | A1 |
20100113959 | Pascual-Leone et al. | May 2010 | A1 |
20100121409 | Kothandaraman et al. | May 2010 | A1 |
20100135553 | Joglekar | Jun 2010 | A1 |
20100137944 | Zhu | Jun 2010 | A1 |
20100152604 | Kaula et al. | Jun 2010 | A1 |
20100179562 | Linker et al. | Jul 2010 | A1 |
20100268298 | Moffitt | Oct 2010 | A1 |
20100324410 | Paek et al. | Dec 2010 | A1 |
20100331883 | Schmitz et al. | Dec 2010 | A1 |
20110004267 | Meadows | Jan 2011 | A1 |
20110005069 | Pianca | Jan 2011 | A1 |
20110040351 | Buston et al. | Feb 2011 | A1 |
20110066407 | Butson et al. | Mar 2011 | A1 |
20110078900 | Pianca et al. | Apr 2011 | A1 |
20110130803 | McDonald | Jun 2011 | A1 |
20110130816 | Howard et al. | Jun 2011 | A1 |
20110130817 | Chen | Jun 2011 | A1 |
20110130818 | Chen | Jun 2011 | A1 |
20110172737 | Davis et al. | Jul 2011 | A1 |
20110184487 | Alberts et al. | Jul 2011 | A1 |
20110191275 | Lujan et al. | Aug 2011 | A1 |
20110196253 | McIntyre et al. | Aug 2011 | A1 |
20110213440 | Fowler et al. | Sep 2011 | A1 |
20110238129 | Moffitt | Sep 2011 | A1 |
20110306845 | Osorio | Dec 2011 | A1 |
20110306846 | Osorio | Dec 2011 | A1 |
20110307032 | Goetz et al. | Dec 2011 | A1 |
20110313500 | Barker et al. | Dec 2011 | A1 |
20120016378 | Pianca et al. | Jan 2012 | A1 |
20120027272 | Akinyemi et al. | Feb 2012 | A1 |
20120046710 | Digiore et al. | Feb 2012 | A1 |
20120046715 | Moffitt et al. | Feb 2012 | A1 |
20120071949 | Pianca et al. | Mar 2012 | A1 |
20120078106 | Dentinger et al. | Mar 2012 | A1 |
20120089205 | Boyden et al. | Apr 2012 | A1 |
20120116476 | Kothandaraman | May 2012 | A1 |
20120165898 | Moffitt | Jun 2012 | A1 |
20120165901 | Zhu et al. | Jun 2012 | A1 |
20120165911 | Pianca | Jun 2012 | A1 |
20120197375 | Pianca et al. | Aug 2012 | A1 |
20120203316 | Moffitt et al. | Aug 2012 | A1 |
20120203320 | Digiore et al. | Aug 2012 | A1 |
20120203321 | Moffitt et al. | Aug 2012 | A1 |
20120207378 | Gupta et al. | Aug 2012 | A1 |
20120226138 | DeSalles et al. | Sep 2012 | A1 |
20120229468 | Lee et al. | Sep 2012 | A1 |
20120265262 | Osorio | Oct 2012 | A1 |
20120265268 | Blum et al. | Oct 2012 | A1 |
20120302912 | Moffitt | Nov 2012 | A1 |
20120303087 | Moffitt et al. | Nov 2012 | A1 |
20120314924 | Carlton et al. | Dec 2012 | A1 |
20120316615 | Digiore et al. | Dec 2012 | A1 |
20120316619 | Goetz et al. | Dec 2012 | A1 |
20130039550 | Blum et al. | Feb 2013 | A1 |
20130060305 | Bokil | Mar 2013 | A1 |
20130105071 | Digiore et al. | May 2013 | A1 |
20130116744 | Blum et al. | May 2013 | A1 |
20130116748 | Bokil et al. | May 2013 | A1 |
20130116749 | Carlton et al. | May 2013 | A1 |
20130116929 | Carlton et al. | May 2013 | A1 |
20130197424 | Bedenbaugh | Aug 2013 | A1 |
20130197602 | Pianca et al. | Aug 2013 | A1 |
20140039587 | Romero | Feb 2014 | A1 |
20140067018 | Carcieri et al. | Mar 2014 | A1 |
20140074180 | Heldman | Mar 2014 | A1 |
20140122379 | Moffitt et al. | May 2014 | A1 |
20140277284 | Chen et al. | Sep 2014 | A1 |
20140353001 | Romero et al. | Dec 2014 | A1 |
20140358208 | Howard et al. | Dec 2014 | A1 |
20140358209 | Romero et al. | Dec 2014 | A1 |
20140358210 | Howard et al. | Dec 2014 | A1 |
20150018915 | Leven | Jan 2015 | A1 |
20150045864 | Howard | Feb 2015 | A1 |
20150051681 | Hershey | Feb 2015 | A1 |
20150066111 | Blum et al. | Mar 2015 | A1 |
20150066120 | Govea | Mar 2015 | A1 |
20150134031 | Moffitt | May 2015 | A1 |
20150151113 | Govea et al. | Jun 2015 | A1 |
Number | Date | Country |
---|---|---|
1048320 | Nov 2000 | EP |
1166819 | Jan 2002 | EP |
1372780 | Jan 2004 | EP |
1559369 | Aug 2005 | EP |
9739797 | Oct 1997 | WO |
9848880 | Nov 1998 | WO |
0190876 | Nov 2001 | WO |
0226314 | Apr 2002 | WO |
0228473 | Apr 2002 | WO |
02065896 | Aug 2002 | WO |
02072192 | Sep 2002 | WO |
03086185 | Oct 2003 | WO |
2004019799 | Mar 2004 | WO |
2004041080 | May 2005 | WO |
2006017053 | Feb 2006 | WO |
2006113305 | Oct 2006 | WO |
20071097859 | Aug 2007 | WO |
20071097861 | Aug 2007 | WO |
2007100427 | Sep 2007 | WO |
2007100428 | Sep 2007 | WO |
2007112061 | Oct 2007 | WO |
2007097224 | Aug 2009 | WO |
2010120823 | Oct 2010 | WO |
2011025865 | Mar 2011 | WO |
2011139779 | Nov 2011 | WO |
2011159688 | Dec 2011 | WO |
2012088482 | Jun 2012 | WO |
Entry |
---|
Nowinski, W. L., et al., “Statistical analysis of 168 bilateral subthalamic nucleus implantations by means of the probabilistic functional atlas.”, Neurosurgery 57(4 Suppl) (Oct. 2005),319-30. |
Obeso, J. A., et al., “Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.”, N Engl J Med., 345{13I, The Deep-Brain Stimulation for Parkinson's Disease Study Group. (Sep. 27, 2001 ),956-63. |
Butson et al.. “Current Steering to control the volume of tissue activated during deep brain stimulation,” vol. 1, No. 1, Dec. 3, 2007, pp. 7-15. |
Patrick, S. K., et al., “Quantification of the UPDRS rigidity scale”, IEEE Transactions on Neural Systems and Rehabilitation Engineering, [see also IEEE Trans. on Rehabilitation Engineering 9(1). (2001),31-41. |
Phillips, M. D., et al., “Parkinson disease: pattern of functional MR imaging activation during deep brain stimulation of subthalamic nucleus—initial experience”, Radiology 239(1). (Apr. 2006),209-16. |
Ericsson, A. et al., “Construction of a patient-specific atlas of the brain: Application to normal aging,” Biomedical Imaging: From Nano to Macro, ISBI 2008, 5th IEEE International Symposium, May 14, 2008, pp. 480-483. |
Kaikai Shen et al., “Atlas selection strategy using least angle regression in multi-atlas segmentation propagatlon,” Biomedical Imaging: From Nano to Macro, 2011, 8th IEEE International Symposium, ISBI 2011, Mar. 30, 2011, pp. 1746-1749. |
Liliane Ramus et al., “Assessing selection methods in the cotnext of multi-atlas based segmentation,” Biomedical Imaging: From Nano to Macro, 2010, IEEE International Symposium, Apr. 14, 2010, pp. 1321-1324. |
Olivier Commowick et al., “Using Frankenstein's Creature Paradigm to Build a Patient Specific Atlas,” Sep. 20, 2009, Medical Image Computing and Computer-Assisted Intervention, pp. 993-1000. |
Lotjonen J.M.P. et al., “Fast and robust multi-atlas segmentation of brain magnetic resonance images,” Neurolmage, Academic Press, vol. 49, No. 3, Feb. 1, 2010, pp. 2352-2365. |
McIntyre, C. C., et al., “How does deep brain stimulation work? Present understanding and future questions.”, J Clin. Neurophysiol. 21 (1 ). (Jan.-Feb. 2004 ),40-50. |
Sanchez Castro et al., “A cross validation study of deep brain stimulation targeting: From experts to Atlas-Based, Segmentation-Based and Automatic Registration Algorithms,” IEEE Transactions on Medical Imaging, vol. 25, No. 11, Nov. 1, 2006, pp. 1440-1450. |
Plaha, P. , et al., “Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.”, Brain 129{Pt 7) (Jul. 2006), 1732-4 7. |
Rattay, F, “Analysis of models for external stimulation of axons”, IEEE Trans. Biomed. Eng. vol. 33 (1986),974-977. |
Rattay, F., “Analysis of the electrical excitation of CNS neurons”, IEEE Transactions on Biomedical Engineering 45 (6). (Jun. 1998),766-772. |
Rose, T. L., et al., “Electrical stimulation with Pt electrodes. VIII. Electrochemically safe charge injection limits with 0.2 ms pulses [neuronal application]”, IEEE Transactions on Biomedical Engineering, 37(11 }, (Nov. 1990), 1118-1120. |
Rubinstein, J. T., et al., “Signal coding in cochlear implants: exploiting stochastic effects of electrical stimulation”, Ann Otol Rhino Laryngol Suppl. 191, (Sep. 2003), 14-9. |
Schwan, H.P., et al., “The conductivity of living tissues.”, Ann NY Acad Sci., 65(6). (AUQ., 1957),1007-13. |
Taylor, R. S., et al., “Spinal cord stimulation for chronic back and leg pain and failed back surgery syndrome: a systematic review and analysis of prognostic factors”, Spine 30(1 ).(Jan. 1, 2005), 152-60. |
Siegel, Ralph M. et al., “Spatiotemporal dynamics of the functional architecture for gain fields in inferior parietal lobule of behaving monkey,” Cerebral Cortex, New York, NY, vol. 17, No. 2, Feb. 2007, pp. 378-390. |
Klein, A. et al., “Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration,” Neurolmage, Academic Press, Orlando, FL, vol. 46, No. 3, Jul. 2009, pp. 786-802. |
Geddes, L. A., et al., “The specific resistance of biological material—a compendium of data for the biomedical engineer and physiologist.”, Med Biol Ena. 5(3). (May 1967),271-93. |
Gimsa, J., et al., “Choosing electrodes for deep brain stimulation experiments-electrochemical considerations.”, J Neurosci Methods. 142(2), (Mar. 30, 2005),251-65. |
Vidailhet, M. , et al., “Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia”, N. Engl J Med. 352(5) (Feb. 3, 2005),459-67. |
Izad, Oliver, “Computationally Efficient Method in Predicating Axonal Excitation,” Dissertation for Master Degree, Department of Biomedical Engineering, Case Western Reserve University, May 2009. |
Jaccard, Paul, “Elude comparative de la distribution florale dans une portion odes Apies et des Jura,” Bulletin de la Societe Vaudoise des Sciences Naturelles (1901), 37:547-579. |
Dice, Lee R., “Measures of the Amount of Ecologic Association Between Species,” Ecology 26(3) (1945): 297-302. doi: 10.2307/ 1932409, http://jstor.org/stable/1932409. |
Rand. WM., “Objective criteria for the evaluation of clustering methods,” Journal of the American Statistical Association (American Statistical Association) 66 (336) (1971 ): 846-850, doi:10.2307/2284239, http://jstor.org/stable/2284239. |
Hubert, Lawrence et al., “Comparing partitions,” Journal of Classification 2(1) (1985): 193-218, doi:10.1007/BF01908075. |
Cover, T.M. et al., “Elements of information theory,” (1991) John Wiley & Sons, New York, NY. |
Meila, Marina “Comparing Clusterings by the Variation of Information,” Learning Theory and Kernel Machines (2003): 173-187. |
Viola, P., et al., “Alignment by maximization of mutual information”, International Journal of Com outer Vision 24(2). ( 1997), 137-154. |
Butson et al. “StimExplorer: Deep Brain Stimulation Parameter Selection Software System,” Acta Neurochirugica, Jan. 1, 2007, vol. 97, No. 2, pp. 569-574. |
Butson et al. “Role of Electrode Design on the Volume of Tissue Activated During Deep Brain Stimulation,” Journal of Neural Engineering, Mar. 1, 2006, vol. 3, No. 1, pp. 1-8. |
Volkmann et al., Indroduction to the Programming of Deep Brain Stimulators, Movement Disorders, vol. 17, Suppl. 3, pp. S181-S187 (2002). |
Miocinovic et al. “Cicerone: Stereotactic Neurophysiological Recording and Deep Brain Stimulation Electrode Placement Software System,” Acta Neurochirurgica Suppl., Jan. 1, 2007, vol. 97, No. 2, pp. 561-567. |
Schmidt et al. “Sketching and Composing Widgets for 3D Manipulation,” Eurograohics, Apr. 2008, vol. 27, No. 2, pp. 301-310. |
Volkmann, J. , et al., “Basic algorithms for the programming of deep brain stimulation in Parkinson's disease”, Mov Disord., 21 Suppl 14. (Jun. 2006),S284-9. |
Walter, B. L., et al., “Surgical treatment for Parkinson's disease”. Lancet Neural. 3(12). (Dec. 2004),719-28. |
Wei, X. F., et al., “Current density distributions, field distributions and impedance analysis of segmented deep brain stimulation electrodes”, J Neural Eng .. 2(4). (Dec. 2005), 139-47. |
Zonenshayn, M., et al., “Location of the active contact within the subthalamic nucleus (STN) in the treatment of Parkinson's disease.” Surg Neural., 62(3) (Sep. 2004),216-25. |
Micheli-Tzanakou, E., et al., “Computational Intelligence for target assesment in Parkinson's disease”, Proceedings of SPIE vol. 4479. Applications and Science of Neural Networks, Fuzzy Systems, and Evolutionary Computation IV,(2001),54-69. |
Miocinovic, S., et al., “Sensitivity of temporal excitation properties to the neuronal element activated by extracellular stimulation”, J Neurosci Methods. 132(1). (Jan. 15, 2004), 91-9. |
Hunka, K. et al., Nursing Time to Program and Assess Deep Brain Stimulators in Movement Disorder Patients, J. Neursci Nurs., 37: 204-10 (Aug. 2005). |
Montgomery, E. B., et al., “Mechanisms of deep brain stimulation and future technical developments.”, Neural Res. 22(3). (Apr. 2000),259-66. |
Merrill, D. R., et al., “Electrical stimulation of excitable tissue: design of efficacious and safe protocols”, J Neurosci Methods. 141(2), (Feb. 15, 2005), 171-98. |
Fisekovic et al., “New Controller for Functional Electrical Stimulation Systems”, Med. Eng. Phys. 2001; 23:391-399. |
Zhang, Y., et al., “Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy,” Neuroimage 52(4) (2010), pp. 1289-1301. |
““BioPSE” The Biomedical Problem Solving Environment”, htt12://www.sci.utah.edu/cibc/software/index.html, MCRR Center for Integrative Biomedical Computing,(2004). |
Andrews, R. J., “Neuroprotection trek—the next generation: neuromodulation I. Techniques—deep brain stimulation, vagus nerve stimulation, and transcranial magnetic stimulation.”, Ann NY Acad Sci. 993. (May 2003),1-13. |
Carnevale, N.T. et al., “The Neuron Book,” Cambridge, UK: Cambridge University Press (2006), 480 pages. |
Chaturvedi: “Development of Accurate Computational Models for Patient-Specific Deep Brain Stimulation,” Electronic Thesis or Dissertation, Jan. 2012, 162 pages. |
Chaturvedi, A. et al.: “Patient-specific models of deep brain stimulation: Influence of field model complexity on neural activation predictions.” Brain Stimulation, Elsevier, Amsterdam, NL, vol. 3, No. 2 Apr. 2010, pp. 65-77. |
McIntyre, C.C., et al., “Modeling the excitablitity of mammalian nerve fibers: influence of afterpotentials on the recovery cycle,” J Neurophysiol, 87(2) (Feb. 2002), pp. 995-1006. |
Peterson, et al., “Predicting myelinated axon activation using spatial characteristics of the extracellular field,” Journal of Neural Engineering, 8 (2011), 12 pages. |
Warman, et al., “Modeling the Effects of Electric Fields on nerver Fibers; Dermination of Excitation Thresholds,”IEEE Transactions on Biomedical Engineering, vol. 39, No. 12 (Dec. 1992), pp. 1244-1254. |
Wesselink, et al., “Analysis of Current Density and Related Parameters in Spinal Cord Stimulation,” IEEE Transactions on Rehabilitation Engineering, vol. 6, No. 2 Jun. 1998, pp. 200-207. |
Andrews, R. J., “Neuroprotection trek—the next generation: neuromodulation II. Applications—epilepsy, nerve regeneration, neurotrophins.”, Ann Ny Acad Sci. 993 (May 2003), 14-24. |
Astrom, M. , et al., “The effect of cystic cavities on deep brain stimulation in the basal ganglia: a simulation-based study”, J Neural Eng., 3(2), (Jun. 2006).132-8. |
Bazin et al., “Free Software Tools for Atlas-based Volumetric Neuroimage Analysis”. Proc. SPIE 5747, Medical Imaging 2005: Image Processing, 1824 May 5, 2005. |
Back, C. , et al., “Postoperative Monitoring of the Electrical Properties of Tissue and Electrodes in Deep Brain Stimulation”, Neuromodulation, 6(4), (Oct. 2003 )248-253. |
Baker, K. B., et al., “Evaluation of specific absorption rate as a dosimeter of MRI-related implant heating”, J Magn Reson Imaging., 20(2), (Aug. 2004),315-20. |
Brown, J. “Motor Cortex Stimulation,” Neurosurgical Focus ( Sep. 15, 2001) 11(3):E5. |
Budai et al., “Endogenous Opioid Peptides Acting at m-Opioid Receptors in the Dorsal Horn Contribute to Midbrain Modulation of Spinal Nociceptive Neurons,” Journal of Neurophysiology (1998) 79(2): 677-687. |
Cesselin, F. “Opioid and anti-opioid peptides,” Fundamental and Clinical Pharmacology (1995) 9(5): 409-33 (Abstract only). |
Rezai et al., “Deep Brain Stimulation for Chronic Pain” Surgical Management of Pain, Chapter 44 pp. 565-576 (2002). |
Xu, MD., Shi-Ang, article entitled “Comparison of Half-Band and Full-Band Electrodes for Intracochlear Electrical Stimulation”, Annals of Otology, Rhinology & Laryngology (Annals of Head & Neck Medicine & Surgery), vol. 102 (5) pp. 363-367 May 1993. |
Bedard, C. , et al., “Modeling extracellular field potentials and the frequency-filtering properties of extracellular space”, Biophys J .. 86(3). (Mar. 2004), 1829-42. |
Benabid, A. L., et al., “Future prospects of brain stimulation”, Neural Res.;22(3), (Apr. 2000),237-46. |
Brummer, S. B., et al., “Electrical Stimulation with Pt Electrodes: II—Estimation of Maximum Surface Redox (Theoretical Non-Gassing) Limits”, IEEE Transactions on Biomedical Engineering, vol. BME-24, Issue 5, (Sep. 1977),440-443. |
Buston, Christopher R., et al., “Deep Brain Stimulation of the Subthalamic Nucleus: Model-Based Analysis of the Effects of Electrode Capacitance on the Volume of Activation”, Proceedings of the 2nd International IEEE EMBS, (Mar. 16-19, 2005), 196-197. |
Mcintyre, Cameron C. et al., “Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition.” J Neurophysiol, 91(4) (Apr. 2004), pp. 1457-1469. |
Chaturvedi, A., et al., “Subthalamic Nucleus Deep Brain Stimulation: Accurate Axonal Threshold Prediction with Diffusion Tensor Based Electric Field Models”, Engineering in Medicine and Biology Society, 2006. EMBS' 06 28th Annual International Conference of the IEEE, IEEE, Piscataway, NJ USA, Aug. 30, 2006. |
Butson, Christopher et al., “Predicting the Effects of Deep Brain Stimulation with Diffusion Tensor Based Electric Field Models” Jan. 1, 2001, Medical Image Computing and Computer-Assisted Intervention-Mic CAI 2006 Lecture Notes in Computer Science; LNCS, Springer, Berlin, DE. |
Butson, C. R., et al., “Deep brainstimulation interactive visualization system”, Society for Neuroscience vol. 898.7 (2005). |
Hodaie, M., et al., “Chronic anterior thalamus stimulation for intractable epilepsy,” Epilepsia 43(6) (Jun. 2002), pp. 603-608. |
Hoekema, R., et al., “Multigrid solution of the potential field in modeling electrical nerve stimulation,” Comput Biomed Res., 31(5) (Oct. 1998), pp. 348-62. |
Holsheimer, J., et al., “Identification of the target neuronal elements in electrical deep brain stimulation,” Eur J Neurosci., 12(12) (Dec. 2000), pp. 4573-4577. |
Jezernik, S., et al., “Neural network classification of nerve activity recorded in a mixed nerve,” Neurol Res., 23(5) (Jul. 2001), pp. 429-434. |
Jones, DK., et al., “Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging,” Magn. Reson. Med., 42(3) (Sep. 1999), pp. 515-525. |
Krack, P., et al., “Postoperative management of subthalamic nucleus stimulation for Parkinson's disease,” Mov. Disord., vol. 17(suppl 3) (2002), pp. 188-197. |
Le Bihan, D., et al., “Diffusion tensor imaging: concepts and applications,” J Magn Reson Imaging, 13(4) (Apr. 2001), pp. 534-546. |
Lee, D. C., et al., “Extracellular electrical stimulation of central neurons: quantitative studies,” In: Handbook of neuroprosthetic methods, WE Finn and PG Lopresti (eds) CRC Press (2003), pp. 95-125. |
Levy, AL., et al., “An Internet-connected, patient-specific, deformable brain atlas integrated into a surgical navigation system,” J Digit Imaging, 10(3 Suppl 1) (Aug. 1997), pp. 231-237. |
Liu, Haiying, et al., “Intra-operative MR-guided DBS implantation for treating PD and ET,” Proceedings of SPIE vol. 4319, Department of Radiology & Neurosurgery, University of Minnesota, Minneapolis, MN 55455 (2001). pp. 272-276. |
Mcintyre, C. C., et al., “Extracellular stimulation of central neurons: influence of stimulus waveform and frequency on neuronal output,” J. Neurophysiol., 88(4), (Oct. 2002), pp. 1592-1604. |
Mcintyre, C. C. et al., “Microstimulation of spinal motoneurons: a model study,” Proceedings of the 19th Annual international Conference of the IEEE Engineering in Medicine and Biology society, vol. 5, (1997), pp. 2032-2034. |
Mcintyre, Cameron C., et al., “Model-based Analysis of deep brain stimulation of the thalamus,” Proceedings of the Second joint EMBS/BM ES Conference, vol. 3, Annual Fall Meeting of the Biomedical Engineering Society (Cal. No. 02CH37392) IEEEPiscataway, NJ (2002), pp. 2047-2048. |
Mcintyre, C. C., et al., “Model-based design of stimulus trains for selective microstimulation of targeted neuronal populations,” Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 1 (2001), pp. 806-809. |
Mcintyre, C. C., et al., Model-based design of stimulus waveforms for selective microstimulation in the central nervous system,, Proceedings of the First Joint [Engineering in Medicine and Biology, 1999. 21st Annual Conf. and the 1999 Annual FallMeeting of the Biomedical Engineering Soc.] BM ES/EMBS Conference, vol. 1 (1999), p. 384. |
Mcintyre, Cameron C., et al., “Modeling the excitability of mammalian nerve fibers: influence of aflerpotentials on the recovery cycle,” J Neurophysiol, 87(2) (Feb. 2002), pp. 995-1006. |
Mcintyre, Cameron C., et al., “Selective microstimulation of central nervous system neurons,” Annals of biomedical engineering, 28(3) (Mar. 2000), pp. 219-233. |
Mcintyre, C. C., et al., “Sensitivity analysis of a model of mammalian neural membrane,”Biol Cybern., 79(1) (Jul. 1998), pp. 29-37. |
Mcintyre, Cameron C., et al., “Uncovering the mechanism(s) of deep brain stimulation: activation, inhibition, or both,” Clin Neurophysiol, 115(6) (Jun. 2004), pp. 1239-48. |
Mcintyre, Cameron C., et al., “Unconvering the mechanism of deep brain stimulation for Parkinson's disease through functional imagins, neural recording, and neural modeling,” Crit Rev Biomed Eng., 30(4-6) (2002), pp. 249-281. |
Mouine et al. “Multi-Strategy and Multi-Algorithm Cochlear Prostheses”, Biomed. Sci. Instrument, 2000 36:233-238. |
Mcintyre, Cameron C., et al., “Electric Field and Stimulating Influence generated by Deep Brain Stimulation of the Subthalarnaic Nucleus,” Clinical Neurophysiology, 115(3) (Mar. 2004), pp. 589-595. |
Mcintyre, Cameron C., et al., “Electric field generated by deep brain stimulation of the subthalamic nucleus,” Biomedical Engineering Society Annual Meeting, Nashville TN (Oct. 2003), 16 pages. |
McIntyre, Cameron C., et al., “Excitation of central nervous system neurons by nonuniform electric fields,” Biophys. J., 76(2) (1999), pp. 878-888. |
McNeal, DR., et al., “Analysis of a model for excitation of myelinated nerve,” IEEE Trans Biomed Eng., vol. 23 (1976), pp. 329-337. |
Micheli-Tzanakou, E. , et al., “Computational Intelligence for target assessment in Parkinson's disease,” Proceedings of SPIE vol. 4479, Applications and Science of Neural Networks, Fuzzy Systems, and Evolutionary Computation IV (2001 ), pp. 54-69. |
Miocinovic, S., et al., “Computational analysis of subthalamic nucleus and lenticular fasciculus activation during therapeutic deep brain stimulation,” J Neurophysiol., 96(3) (Sep. 2006), pp. 1569-80. |
Miranda, P. C., et al., “The distribution of currents inducedin the brain by Magnetic Stimulation: a finite element analysis incorporating OT-MRI-derived conductivity data,” Proc. Intl. Soc. Mag. Reson. Med. 9 (2001 ), p. 1540. |
Miranda, P. C., et al., “The Electric Field induced in the Brain by Magnetic Stimulation: A 3-D Finite-Element Analysis of the Effect of Tissue Heterogeneity and Anisotropy,” IEEE Transactions on Biomedical Enginering, 50(9) (Sep. 2003), pp. 1074-1085. |
Moffitt, MA., et al., “Prediction of myelinated nerve fiber stimulation thresholds: limitations of linear models,” IEEE Transactions on Biomedical Engineering, 51 (2) (2003), pp. 229-236. |
Moro, E, et al., “The impact on Parkinson's disease of electrical parameter settings in STN stimulation,” Neurology, 59 (5) (Sep. 10, 2002), pp. 706-713. |
Nowak, LG., et al., “Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. I. Evidence from chronaxie measurements,” Exp. Brain Res., 118(4) (Feb. 1998), pp. 477-488. |
Nowak, LG., et al., “Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments,” Exp. Brain Res 118(4) (Feb. 1998), pp. 489-500. |
O'Suilleabhain, PE., et al., “Tremor response to polarity, voltage, pulsewidth and frequency of thalamic stimulation,” Neurology, 60(5) (Mar. 11, 2003). pp. 786-790. |
Pierpaoli, C., et al., “Toward a quantitative assessment of diffusion anisotropy,” Magn Reson Med., 36(6) (Dec. 1996), pp. 893-906. |
Plonsey, R., et al., “Considerations of quasi-stationarity in electrophysiological systems,” Bull Math Biophys., 29(4) (Dec. 1967), pp. 657-664. |
Ranck, J B., “Specific impedance of rabbit cerebral cortex,” Exp. Neurol vol. 7 (Feb. 1963), pp. 144-152. |
Ranck, J B., et al., “The Specific impedance of the dorsal columns of the cat: an anisotropic medium,” Exp. Neurol., 11 (Apr. 1965), pp. 451-463. |
Ranck, J B., Which elements are excited in electrical stimulation of mammalian central nervous system: a review, Brain Res., 98(3) (Nov. 21, 1975), pp. 417-440. |
Rattay, F., et al., “A model of the electrically excited human cochlear neuron. I. Contribution of neural substructures to the generation and propagation of spikes,” Hear Res., 153(1-2) (Mar. 2001), pp. 43-63. |
Rattay, F., “A model of the electrically excited human cochlear neuron. II. Inftuence of the three-dimensional cochlear structure on neural excitability,” Hear Res., 153(1-2) (Mar. 2001), pp. 64-79. |
Rattay, F., “Arrival at Functional Electrostimulation by modelling of fiber excitation,” Proceedings of the Ninth annual Conference of the IEEE Engineering in Medicine and Biology Society (1987), pp. 1459-1460. |
Rattay, F., “The inftuence of intrinsic noise can preserve the temporal fine structure of speech signals in models of electrically stimulated human cochlear neurones,” Journal of Physiology, Scientific Meeting of the Physiological Society, London, England, UK Apr. 19-21, 1999 (Jul. 1999), p. 170P. |
Rizzone, M., et al., “Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: effects of variation in stimulation parameters,” J. Neurol. Neurosurg. Psychiatry. 71(2) (Aug. 2001), pp. 215-219. |
Saint-Cyr, J. A., et al., “Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging,” J. Neurosurg., 87(5) (Nov. 2002), pp. 1152-1166. |
Sances, A., et al., “In Electroanesthesia: Biomedical and Biophysical Studies,” A Sances and SJ Larson, Eds., Academic Press, NY (1975), pp. 114-124. |
SI. Jean, P., et al., “Automated atlas integration and interactive three-dimensional visualization tools for planning and guidance in functional neurosurgery,” IEEE Transactions on Medical Imaging, 17(5) (1998), pp. 672-680. |
Starr, P.A., et al., “Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations,” J. Neurosurg.. 97(2) (Aug. 2002), pp. 370-387. |
Sterio, D., et al., “Neurophysiological refinement of subthalamic nucleus targeting,” Neurosurgery, 50(1) (Jan. 2002), pp. 58-69. |
Struijk, J. J., et al., “Excitation of dorsal root fibers in spinal cord stimulation: a theoretical study,” IEEE Transactions on Biomedical Engineering, 40(7) (Jul. 1993), pp. 632-639. |
Struijk, J J., et al., “Recruitment of dorsal column fibers in spinal cord stimulation: inftuence of collateral branching,” IEEE Transactions on Biomedical Engineering, 39(9) (Sep. 1992), pp. 903-912. |
Tamma, F., et al., “Anatomo-clinical correlation of intraoperative stimulation-induced side-effects during HF-DBS of the subthalamic nucleus,” Neurol Sci., vol. 23 (Suppl 2) (2002), pp. 109-110. |
Tarler, M., et al., “Comparison between monopolar and tripolar configurations in chronically implanted nerve cuff electrodes,” IEEE 17th Annual Conference Engineering in Medicine and Biology Society, vol. 2 (1995), pp. 1093-109. |
Testerman, Roy L., “Coritical response to callosal stimulation: A model for determining safe and efficient stimulus parameters,” Annals of Biomedical Engineering, 6(4) (1978), pp. 438-452. |
Tuch, D.S., et al., “Conductivity mapping of biological tissue using diffusion MRI,” Ann NY Acad Sci., 888 (Oct. 30, 1999), pp. 314-316. |
Tuch, D.S., et al., “Conductivity tensor mapping of the human brain using diffusion tensor MRI,” Proc Nall Aced Sci USA, 98(20) (Sep. 25, 2001), pp. 11697-11701. |
Veraart, C., et al., “Selective control of muscle activation with a multipolar nerve cuff electrode,” IEEE Transactions on Biomedical Engineering, 40(7) (Jul. 1993), pp. 640-653. |
Vercueil, L., et al., “Deep brain stimulation in the treatment of severe dystonia,” J. Neural., 248(8) (Aug. 2001 ), pp. 695-700. |
Vitek, J. L., “Mechanisms of deep brain stimulation: excitation or inhibition,” Mov. Disord., vol. 17 (Suppl. 3) (2002), pp. 69-72. |
Voges, J., et al., “Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position,” J. Neurosurg., 96(2) (Feb. 2002), pp. 269-279. |
Wakana, S., et al., “Fiber tract-based atlas of human white matter anatomy,” Radiology, 230(1) (Jan. 2004), pp. 77-87. |
Alexander, DC., et al., “Spatial transformations of diffusion tensor magnetic resonance images,” IEEE Transactions on Medical Imaging, 20 (11), (2001), pp. 1131-1139. |
Wu, Y. R., et al., “Does Stimulation of the GPi control dyskinesia by activating inhibitory axons?,” Mov. Disord., vol. 16 (2001), pp. 208-216. |
Yelnik, J., et al., “Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method,” J Neurosurg., 99(1) (Jul. 2003), pp. 89-99. |
Yianni, John, et al., “Globus pallidus internus deep brain stimulation for dystonic conditions: a prospective audit,” Mov. Disord., vol. 18 (2003), pp. 436-442. |
Zonenshayn, M., et al., “Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting,” Neurosurgery, 47(2) (Aug. 2000), pp. 282-294. |
Voghell et al., “Programmable Current Source Dedicated to Implantable Microstimulators” ICM '98 Proceedings of the Tenth International Conference, pp. 67-70. |
Butson, Christopher R., et al., “Patient-specific analysis of the volume of tissue activated during deep brain stimulation”, NeuroImage. vol. 34, (2007),661-670. |
Adler, DE., et al., “The tentorial notch: anatomical variation, morphometric analysis, and classification in 100 human autopsy cases,” J. Neurosurg., 96(6), (Jun. 2002), pp. 1103-1112. |
Jones et al., “An Advanced Demultiplexing System for Physiological Stimulation”, IEEE Transactions on Biomedical Engineering, vol. 44 No. 12 Dec. 1997, pp. 1210-1220. |
Alo, K. M., et al., “New trends in neuromodulation for the management of neuropathic pain,” Neurosurgery, 50(4), (Apr. 2002), pp. 690-703, discussion pp. 703-704. |
Ashby, P. et al., “Neurophysiological effects of stimulation through electrodes in the human subthaiemic nucleus,” Brain, 122 (PI 10), (Oct. 1999), pp. 1919-1931. |
Baker, K. B., et al., “Subthalamic nucleus deep brain stimulus evoked potentials: Physiological and therapeutic implications,” Movement Disorders, 17(5), (Sep./Ocl. 2002), pp. 969-983. |
Bammer, R, et al., “Diffusion tensor imaging using single-shot Sense-EPI”, Magn Reson Med., 48(1 ), (Jul. 2002), pp. 128-136. |
Basser, P J., et al., “MR diffusion tensor spectroscopy and imaging,” Biophys J., 66(1 ), (Jan. 1994), pp. 259-267. |
Basser, P J., et al., “New currents in electrical stimulation of excitable tissues,” Annu Rev Biomed Eng., 2, (2000), pp. 377-397. |
Benabid, AL., et al., “Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders,” J. Neurosurg., 84(2), (Feb. 1996), pp. 203-214. |
Benabid, AL., et al., “Combined (Ihalamotoy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease,” Appl Neurophysiol, vol. 50, (1987), pp. 344-346. |
Benabid, A L., et al., “Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus,” Lancet, 337 (8738), (Feb. 16, 1991 ), pp. 403-406. |
Christensen, Gary E., et al., “Volumetric transformation of brain anatomy,” IEEE Transactions on Medical Imaging, 16(6), (Dec. 1997), pp. 864-877. |
Cooper, S , et al., “Differential effects of thalamic stimulation parameters on tremor and paresthes as in essential tremor,” Movement Disorders, 17(Supp. 5), (2002), p. S193. |
Coubes, P, et al., “Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus,” Lancet, 355 (9222), (Jun. 24, 2000), pp. 2220-2221. |
Dasilva, A.F. M, et al., “A Primer Diffusion Tensor Imaging of Anatomical Substructures,” Neurosurg. Focus; 15(1) (Jul. 2003), pp. 1-4. |
Dawant, B. M., et al., “Compuerized atlas-guided positioning of deep brain stimulators: a feasibility study,” Biomedical Image registration, Second International Workshop; WBIR 2003, Revised Papers (Lecture notes in Comput. Sci. vol. (2717), Springer-Verlag Berlin, Germany(2003), pp. 142-150. |
Finnis, K. W., et al., “3-D functional stales of subcortical structures for image guided stereotactic neurosurgery,” Neuroimage, vol. 9, No. 6, Iss. 2 (1999), p. S206. |
Finnis, K. W., et al., “3D Functional Database of Subcorticol Structures for Surgical Guidance in Image Guided Stereotactic Neurosurgery,” Medical Image Computing and Computer-Assisted Intervention—MICCAI'99, Second International Conference.Cambridge, UK, Sep. 19-22, 1999, Proceedings (1999), pp. 758-767. |
Finnis, K. W., et al., “A 3-Dimensional Database of Deep Brain Functional Anatomy, and Its Application to Image-Guided Neurosurgery,” Proceedings of the Third International Conference on Medical Image Computing and Computer-Assisted lntervention.Lecture Notes in Computer Science; vol. 1935 (2000), pp. 1-8. |
Finnis, K. W., et al., “A functional database for guidance of surgical and therapeutic procedures in the deep brain,” Proceedings of the 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 3 (2000), pp. 1787-1789. |
Finnis, K. W., et al., “Application of a Population Based Electrophysiological Database to the Planning and Guidance of Deep Brain Stereotactic Neurosurgery,” Proceedings of the 5th International Conference on Medical Image Computing and Computer-Assisted Intervention-Part 11, Lecture Notes in Computer Science; vol. 2489 (2002), pp. 69-76. |
Finnis, K. W., et al., “Subcortical physiology deformed into a patient-specific brain atlas for image-guided stereotaxy,” Proceedings of SPIE—vol. 4681 Medical Imaging 2002: Visualization, Image-Guided Procedures, and Display (May 2002), pp. 184-195. |
Finnis, Krik W., et al., “Three-Dimensional Database of Subcortical Electrophysiology for Image-Guided Stereotatic Functional Neurosurgery,” IEEE Transactions on Medical Imaging, 22(1) (Jan. 2003), pp. 93-104. |
Gabriels, L , et al., “Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases,” Acta Psychiatr Scand., 107(4) (2003), pp. 275-282. |
Goodall, E. V., et al., “Modeling study of activation and propagation delays furing stimulation of peripheral nerve fibers with a tripolar cuff electrode,” IEEE Transactions on Rehabilitation Engineering, [see also IEEE Trans. on Neural Systems and Rehabilitation], 3(3) (Sep. 1995), pp. 272-282. |
Goodall, E. V., et al., “Position-selective activation of peripheral nerve fibers with a cuff electrode,” IEEE Transactions on Biomedical Engineering, 43(8) (Aug. 1996), pp. 851-856. |
Goodall, E. V., “Simulation of activation and propagation delay during tripolar neural stimulation,” Proceedings of the 15th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (1993), pp. 1203-1204. |
Grill, WM., “Modeling the effects of electric fields on nerve fibers: inftuence of tissue electrical properties,” IEEE Transactions on Biomedical Engineering, 46(8) (1999), pp. 918-928. |
Grill, W. M., et al., “Neural and connective tissue response to long-term implantation of multiple contact nerve cuff electrodes,” J Biomed Mater Res., 50(2) (May 2000), pp. 215-226. |
Grill, W. M., “Neural modeling in neuromuscular and rehabilitation research,” Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vol. 4 (2001 ), pp. 4065-4068. |
Grill, W. M., et al., “Non-invasive measurement of the input-output properties of peripheral nerve stimulating electrodes,” Journal of Neuroscience Methods, 65(1) (Mar. 1996), pp. 43-50. |
Grill, W. M., et al., “Quantification of recruitment properties of multiple contact cuff electrodes,” IEEE Transactions on Rehabilitation Engineering, [see also IEEE Trans. on Neural Systems and Rehabilitation], 4(2) (Jun. 1996), pp. 49-62. |
Grill, W. M., “Spatially selective activation of peripheral nerve for neuroprosthetic applications,” Ph.D. Case Western Reserve University, (1995), pp. 245 pages. |
Grill, W. M., “Stability of the input-output properties of chronically implanted multiple contact nerve cuff stimulating electrodes,” IEEE Transactions on Rehabilitation Engineering [see also IEEE Trans. on Neural Systems and Rehabilitation] (1998), pp. 364-373. |
Grill, W. M., “Stimulus waveforms for selective neural stimulation,” IEEE Engineering in Medicine and Biology Magazine, 14(4) (Jul.-Aug. 1995), pp. 375-385. |
Grill, W. M., et al., “Temporal stability of nerve cuff electrode recruitment properties,” IEEE 17th Annual Conference Engineering in Medicine and Biology Society, vol. 2 (1995), pp. 1089-1090. |
Gross, RE., et al., “Advances in neurostimulation for movement disorders,” Neurol Res., 22(3) (Apr. 2000), pp. 247-258. |
Guridi et al., “The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurological dogma,” Brain, vol. 124, 2001, pp. 5-19. |
Haberler, C, et al., “No tissue damage by chronic deep brain stimulation in Parkinson's disease,” Ann Neurol., 48(3) (Sep. 2000), pp. 372-376. |
Hamel, W, et al., “Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts,” J Neural Neurosurg Psychiatry, 74(8) (Aug. 2003), pp. 1036-1046. |
Hanekom, “Modelling encapsulation tissue around cochlear implant electrodes,” Med. Biol. Eng. Comput. vol. 43 (2005), pp. 47-55. |
Haueisen, J , et al., “The influence of brain tissue anisotropy on human EEG and MEG,” Neuroimage, 15(1) (Jan. 2002), pp. 159-166. |
D'Haese et al. Medical Image Computing and Computer-Assisted Intervention—MICCAI 2005 Lecture Notes in Computer Science, 2005, vol. 3750, 2005, 427-434. |
Rohde et al. IEEE Transactions on Medical Imaging, vol. 22 No. 11, 2003 p. 1470-1479. |
Miocinovic et al., “Stereotactiv Neurosurgical Planning, Recording, and Visualization for Deep Brain Stimulation in Non-Human Primates”, Journal of Neuroscience Methods, 162:32-41, Apr. 5, 2007, XP022021469. |
Gemmar et al., “Advanced Methods for Target Navigation Using Microelectrode Recordings in Stereotactic Neurosurgery for Deep Brain Stimulation”, 21st IEEE International Symposium on Computer-Based Medical Systems, Jun. 17, 2008, pp. 99-104, XP031284774. |
Acar et al., “Safety Anterior Commissure-Posterior Commissure-Based Target Calculation of the Subthalamic Nucleus in Functional Stereotactic Procedures”, Stereotactic Funct. Neurosura., 85:287-291, Aug. 2007. |
Andrade-Souza, “Comparison of Three Methods of Targeting the Subthalamic Nucleus for Chronic Stimulation in Parkinson's Disease”, Neurosurgery, 56:360-368, Apr. 2005. |
Anheim et al., “Improvement in Parkinson Disease by Subthalamic Nucleus Stimulation Based on Electrode Placement”, Arch Neural., 65:612-616, May 2008. |
Butson et al., “Tissue and Electrode Capacitance Reduce Neural Activation Volumes During Deep Brain Stimulation”, Clinical Neurophysiology, 116:2490-2500, Oct. 2005. |
Butson et al., “Sources and Effects of Electrode impedance During Deep Brain Stimulation”, Clinical Neurophysiology, 117:44 7-454, Dec. 2005. |
D'Haese et al., “Computer-Aided Placement of Deep Brain Stimulators: From Planning to Intraoperative Guidance”, IEEE Transaction on Medical Imaging, 24:1469-1478, Nov. 2005. |
Gross et al., “Electrophysiological Mapping for the Implantation of Deep Brain Stimulators for Parkinson's Disease and Tremor”, Movement Disorders, 21 :S259-S283, Jun. 2006. |
Halpern et al., “Brain Shift During Deep Brain Stimulation Surgery for Parkinson's Disease”,Stereotact Funct. Neurosurg., 86:37-43, published online Sep. 2007. |
Herzog et al., “Most Effective Stimulation Site in Subthalamic Deep Brain Stimulation for Parkinson's Disease”, Movement Disorders, 19:1050-1099, published on line Mar. 2004. |
Jeon et al., A Feasibility Study of Optical Coherence Tomography for Guiding Deep Brain Probes, Journal of Neuroscience Methods, 154:96-101, Jun. 2006. |
Khan et al., “Assessment of Brain Shift Related to Deep Brain Stimulation Surgery”, Sterreotact Funct. Neurosurg., 86:44-53, published online Sep. 2007. |
Koop et al., “Improvement in a Quantitative Measure of Bradykinesia After Microekectrode Recording in Patients with Parkinson's Disease During Deep Brain Stimulation Surgery”, Movement Disorders, 21 :673-678, published on line Jan. 2006. |
Lemaire et al., “Brain Mapping in Stereotactic Surgery: A Brief Overview from the Probabilistic Targeting to the Patient-Based Anatomic Mapping”, NeuroImage, 37:S109-S115, available online Jun. 2007. |
Machado et al., “Deep Brain Stimulation for Parkinson's Disease: Surgical Technique and Perioperative Management”, Movement Disorders, 21 :S247-5258, Jun. 2006. |
Maks et al., “Deep Brain Stimulation Activation Volumes and Their Association with Neurophysiological Mapping and Therapeutic Outcomes”, Downloaded from jnnp.bmj.com, pp. 1-21, published online Apr. 2008. |
Moran et al., “Real-Time Refinment of Subthalamic Nucleous Targeting Using Bayesian Decision-Making on the Root Mean Square Measure”, Movement Disorders, 21: 1425-1431, published online Jun. 2006. |
Sakamoto et al., “Homogeneous Fluorescence Assays for RNA Diagnosis by Pyrene-Conjugated 2′-0-Methyloligoribonucleotides”, Nucleosides, Nucleotides, and Nucleric Acids, 26:1659-1664, on line publication Oct. 2007. |
Winkler et al., The First Evaluation of Brain Shift During Functional Neurosurgery by Deformation Field Analysis. J. Neural. Neurosurg. Psychiatry, 76:1161-1163, Aug. 2005. |
Yelnik et al., “A Three-Dimensional, Histological and Deformable Atlas of the Human Basal J Ganglia. I. Atlas Construction Based on Immunohistochemical and MRI Data”, NeuroImage, 34:618,-638,Jan. 2007. |
Ward, H. E., et al., “Update on deep brain stimulation for neuropsychiatric disorders,” Neurobiol Dis 38 (3) (2010), pp. 346-353. |
Alberts et al. “Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients,” Brain (2008), 131, 3348-3360, Abstract. |
An, et al., “Prefronlal cortical projections to longitudinal columns in the midbrain periaqueductal gray in macaque monkeys,” J Comp Neural 401 (4) (1998), pp. 455-479. |
Carmichael, S. T., et al., Connectional networks within the orbital and medial prefronlal cortex of macaque monkeys, J Comp Neural 371 (2) (1996), pp. 179-207. |
Croxson, et al., “Quantitative investigation of connections of the prefronlal cortex in the human and macaque using probabilistic diffusion tractography,” J Neurosci 25 (39) (2005), pp. 8854-8866. |
Frankemolle, et al., “Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming,” Brain 133 (2010), pp. 746-761. |
Freedman, et al., “Subcortical projections of area 25 (subgenual cortex) of the macaque monkey,” J Comp Neurol 421 (2) (2000), pp. 172-188. |
Giacobbe, et al., “Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation,” Exp Neural 219 (1) (2009), pp. 44-52. |
Goodman, et al., “Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design,” Biol Psychiatry 67 (6) (2010), pp. 535-542. |
Greenberg, et al., “Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience,” Mol Psychiatry 15 (1) (2010), pp. 64-79. |
Greenberg, et al., “Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder,” Neuropsychopharmacology 31 (11) (2006), pp. 2384-2393. |
Gutman, et al., “A tractography analysis of two deep brain stimulation white matter targets for depression,” Biol Psychiatry 65 (4) (2009), pp. 276-282. |
Haber, et al., “Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning,” J Neurosci 26 (32) (2006), pp. 8368-8376. |
Haber, et al., “Cognitive and limbic circuits that are affected by deep brain stimulation,” Front Biosci 14 (2009), pp. 1823-1834. |
Hines, M. L., et al., “The Neuron simulation environment,” Neural Comput., 9(6) (Aug. 15, 1997), pp. 1179-1209. |
Hua, et al., “Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific region targeted quantification,” Neuroimage 39 (1) (2008), pp. 336-347. |
Johansen-Berg, et al., “Anatomical connectivity of the subgenual cinguiate region targeted with deep brain stimulation for treatment resistant depression,” Cereb Cortex 18 (6) (2008), pp. 1374-1383. |
Kopell, et al., “Deep brain stimulation for psychiatric disorders,” J Clin Neurophysiol 21 (1) (2004), pp. 51-67. |
Lozano, et al., “Subcallosalcingulate gyrus deep brain stimulation for treatment-resistant depression,” Biol Psychiatry 64 (6) (2008), pp. 461-467. |
Lujan, et al., “Tracking the mechanisms of deep brain stimulation for neuropsychiatric disorders,” Front Biosci 13 (2008), pp. 5892-5904. |
Lujan, J.L. et al., “Automated 3-Dimensional Brain Atlas Fitting to Microelectrode Recordings from Deep Brain Stimulation Surgeries,” Stereotact. Funel. Neurosurg. 87(2009), pp. 229-240. |
Machado. et al., “Functional topography of the ventral striatum and anterior limb of the internal capsile determined by electrical stimulation of awake patients,” Clin Neurophysiol 120 (11) (2009), pp. 1941-1948. |
Mayberg, H. S., et al., “Deep brain stimulation for treatment-resistant depression,” Neuron, 45(5) (Mar. 3, 2005), pp. 651-660. |
Mayberg, H. S., et al., “Limbic-cortical dysregulation: a proposed model of depression,” J Neuropsychiatry Clin Neurosci. 9 (3) (1997), pp. 471-481. |
McIntyre,C. C., et al., “Network perspectives on the mechanisms of deep brain stimulation,” Neurobiol Dis 38 (3) , (2010), pp. 329-337. |
Miocinovic, S., et al., “Experimental and theoretical characterization of the voltage distribution generated by deep drain stimulation,” Exp Neurol 216 (i) (2009), pp. 166-176. |
Saxena, et al., “Cerebral glucose metabolism in obsessive-compulsive hoarding,” Am J Psychiatry. 161 (6) (2004), pp. 1038-1048. |
Viola, et al., “Importance-driven focus of attention,” IEEE Trans Vis Comput Graph 12 (5) (2006), pp. 933-940. |
Wakana, S., et al., “Reproducibility of quantitative tractography methods applied to cerebral white matter,” Neuroimage 36 (3) (2007), pp. 630-644. |
Mayr et al., “Basic Design and Construction of the Vienna FES Implants: Existing Solutions and Prospects for New Generations of Implants”, Medical Engineering & Physics, 2001; 23:53-60. |
McIntyre, Cameron , et al., “Finite element analysis of the current-density and electric field generated by metal microelectrodes”, Ann Biomed Eng . 29(3), (2001 ),227-235. |
Foster, K. R., et al., “Dielectric properties of tissues and biological materials: a critical review.” Grit Rev Biomed Ena. 17(1 ). {1989),25-104. |
Limousin, P., et al., “Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease”, N Engl J Med .. 339(16), (Oct. 15, 1998), 1105-11. |
Kitagawa, M., et al., “Two-year follow-up of chronic stimulation of the posterior subthalamic white matter for tremor-dominant Parkinson's disease.”, Neurosurgery. 56(2), (Feb. 2005)281-9. |
Johnson, M. D., et al., “Repeated voltage biasing improves unit recordings by reducing resistive tissue impedances”, IEEE Transactions on Neural Systems and Rehabilitation Engineering, [see also IEEE Trans. on Rehabilitation Engineering (2005), 160-165. |
Holsheimer, J. , et al., “Chronaxie calculated from current-duration and voltage-duration data”, J Neurosci Methods. 97(1). (Apr. 1, 2000),45-50. |
Hershey, T., et al., “Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD.”, Neurology 61(6). (Sep. 23, 2003),816-21. |
Hemm, S. , et al., “Evolution of Brain Impedance in Dystonic Patients Treated by GPi Electrical Stimulation”, Neuromodulation 7(2) (Apr. 2004),67-75. |
Hemm, S., et al., “Deep brain stimulation in movement disorders: stereotactic coregistration of two-dimensional electrical field modeling and magnetic resonance imaging.”, J Neurosurg. 103(6): (Dec. 2005)949-55. |
Haslinger, B., et al., “Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease ”, Neuroimage 28(3). (Nov. 15, 2005),598-606. |
Hashimoto, T. , et al., “Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons”, J Neurosci. 23(5). (Mar. 1, 2003),1916-23. |
Hardman, C. D., et al., “Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei”, J Comp Neurol., 445(3). (Apr. 8, 2002),238-55. |
McNaughtan et al., “Electrochemical Issues in Impedance Tomography”, 1st World Congress on Industrial Process Tomography, Buxton, Greater Manchester, Apr. 14-17, 1999. |
Grill, WM., et al., “Electrical properties of implant encapsulation tissue”, Ann Biomed Eng. vol. 22. (1994),23-33. |
Grill, W. M., et al., “Deep brain stimulation creates an informational lesion of the stimulated nucleus”, Neuroreport. 15l7t (May 19, 2004 ), 1137-40. |
International Search Report and Written Opinion for PCT/US2016/039644 dated Dec. 7, 2016. |
Pulliam CL, Heldman DA, Orcutt TH, Mera TO, Giuffrida JP, Vitek JL. Motion sensor strategies for automated optimization of deep brain stimulation in Parkinson's disease. Parkinsonism Relat Disord. Apr. 2015; 21(4):378-82. |
Number | Date | Country | |
---|---|---|---|
20160375258 A1 | Dec 2016 | US |
Number | Date | Country | |
---|---|---|---|
62186172 | Jun 2015 | US |